Ƙararraki da ƙasa: Matsayinsu a cikin yanayin da ake dasu ga ƙwaƙwalwar mutum (2013)

TAMBAYOYI: Yin bita ta hanyar kimiyya na yadda ƙwarewar haɓakawa da haɓakawa suke tare a cikin haɗarin mutum.


Neurosci Biobehav Rev. Rubutun marubucin marubucin; akwai a PMC Nov 1, 2014.

An buga shi a cikin tsari na karshe kamar yadda:

PMCID: PMC3743927

NIHMSID: NIHMS436830

Marco Leyton a , ** da Paul Vezina b , *

An samu sigar ƙarshe da aka gyara ta wannan labarin a Neurosci Biobehav Rev

Duba wasu labaran a cikin PMC waɗanda suka yi nuni da labarin da aka buga.

Ka tafi zuwa ga:

Abstract

Rashin ƙarfi ga halayen jaraba yana da alaƙa da haɓaka biyu da raguwa a cikin aikin mai ɗaukar hoto. An ba da bayanin bayanan martaba biyu a cikin mutane da kuma samfuran dabbobi. Duk da haka, hanyoyin da ke haifar da waɗannan sakamako masu tsaurin ra'ayi da kuma hanyar da suke da alaƙa da halayyar halayyar hauka da bayyanar jaraba sun kasance ba a fayyace ba. A cikin nazarin da muke yi yanzu na karatuttukan mutane, mun bayyana abubuwa da yawa waɗanda zasu iya yin tasiri ko an lura da tashin hankali ko ayyukan hypo-da gabatar da ƙira wanda ya haɗu da tasirin waɗannan maganganun sabanin halayen halayen jaraba. Matsayi ga wannan ƙira shine rawar da kasancewa gabanin kasancewa tare da rashin abubuwan da ke da alaƙa da jaraba da kuma ikon su na bada amsa ga magungunan da ake zagi da sauran lada. Aiki na kashin ciki da kasashe masu karfafa gwiwa na karuwa ne a gaban wadannan lamurra kuma sun ragu cikin rashi. Zaɓuɓɓuka tsakanin waɗannan jihohin na iya ɗaukar nauyin ragewar abubuwan sha'awa yayin da jaraba ke ci gaba da nuna hanyoyin da suka dace don yin niyya a cikin magani.

keywords: Basal ganglia, Yanayi, Dopamine, Magungunan kwayoyi, Gudanar da magani, sarrafa kansa, Tasirin maganadisu mai amfani, Tasirin maganganu masu dauke da sinadarai, Sensitization, Striatum

1. Gabatarwa

Ka'idoji guda biyu da aka saba sabawa sun nuna cewa ci gaban halayen da suka shafi jaraba yana nuna kunna tsarin lada na limbic ta hanyar hyper-versus hypo-activation. Muhawarar ba sabuwa ba ce (misali, Wikler, 1948 , 1973 ; Vogel et al., 1948 ). Kuma matsayin ba zai iya sulhuntawa ba. Shaidu na baya-bayan nan sun nuna yiwuwar bayyanar yanayin ƙarfafawa mai ƙarfi da hyper-versus hypo-active na iya nuna, a wani ɓangare mai mahimmanci, kasancewar da rashin alamun da suka shafi jaraba ( Leyton da Vezina, 2012 ; duba kuma Anagnostaras da Robinson, 1996 ; Anagnostaras et al., 2002 ; Stewart da Vezina, 1988 , 1991 ; Vezina da Leyton, 2009 ). Wannan bita ya mayar da hankali kan shaidar waɗannan yanayi masu canzawa a cikin mutane, yuwuwar cewa mutane na iya bambanta a cikin sauƙin kamuwa da su, da kuma rawar da alamun da suka shafi jaraba ke takawa a cikin bayyanar su. Duk da cewa an yi la'akari da su a yanayin asibiti na ɗan adam, an gwada yawancin ra'ayoyin da aka tattauna a nan a cikin shekaru talatin da suka gabata dalla-dalla a cikin gwaje-gwajen da suka shafi magunguna kafin a fara amfani da su. Tsarin da aka gano a cikin waɗannan nazarin na iya yin tasiri musamman ga fahimtarmu game da rawar da alamun da suka shafi jaraba ke takawa a cikin ƙirƙirar yanayin tunani da halaye a cikin mutane. Don haka za mu fara da ɗan taƙaitaccen bita na wannan wallafe-wallafen kafin mu koma ga tsarin kula da shaidun a cikin mutane.

2. Karataccen karatu a cikin dabbobin dabbobi

Magungunan ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwa kamar amphetamine, cocaine, da nicotine an daɗe da sanin su don haifar da halayyar su na motsawa da tasirin motsa jiki ta hanyar ƙarfafa tsarin mesoaccumbens dopamine (DA). Yawancin binciken kwaskwarima, akasarinsu a cikin jiyyoyi, sunyi nazarin tasirin maimaitawa ga waɗannan kwayoyi akan ilimin halittu da halayyar mutum. Daga cikin ire-iren illolin da ke tattare da bayyanar kwayoyi, biyu sun bayyana wadanda ke da wata ma'ana ta musamman ga fahimtarmu game da shan ƙwayoyi masu wuce gona da iri: haɓaka ƙwarewa ga halayen ƙwaƙwalwa da haɓaka masu tasiri na kwayoyi da kuma ƙirƙirar ƙungiyoyi masu ladabi tsakanin tasirin miyagun ƙwayoyi da ire-irensu. cigaban muhalli. Kodayake abubuwan banbanci daban, waɗannan sakamakon biyu na haɗuwa da kwayoyi suna sananne don yin ma'amala kamar yadda aka bayyana a ƙasa. Yanayin wannan mu'amala da za ta kasance mai matukar bayani ne don fahimtar yadda alamu ke da shaye shaye na iya tasiri ga tsararrakin halaye da dabi'un mutane.

Wani babban wallafe-wallafen da aka yi kafin a fara aiki a asibiti yanzu ya nuna cewa yawan shan magungunan psychostimulant akai-akai yana ƙara tasirin motsa jiki da kwakwalwa na DA da suke samarwa ba kawai ba, har ma mafi mahimmanci adadin ayyukan da dabbobin za su fitar don samun da kuma ba da maganin da kansu ( Mendrek et al., 1998 ; Vezina, 2004 ; Vezina et al., 2007 ). Waɗannan tasirin suna dawwama (ana lura da su makonni zuwa watanni bayan kamuwa da miyagun ƙwayoyi a cikin beraye; Hamamura et al., 1991 ; Paulson et al., 1991 ; Suto et al., 2004 ; Vezina et al., 2002 ), akwai shaidar cewa suna ƙaruwa da girma yayin da lokaci ke shuɗewa ( Vanderschuren da Kalivas, 2000 ; Vezina, 2007 ), kuma ana lura da su bayan kamuwa da su lokaci-lokaci ( Robinson da Becker, 1986 ; Zimmer et al., 2012 ), wani tsari da galibi ke da alaƙa da kamuwa da farko ga miyagun ƙwayoyi da fara amfani da miyagun ƙwayoyi. Tare, waɗannan binciken suna goyan bayan shawarar cewa fahimtar amsawar mesoaccumbens DA neuron na iya haifar da sauyawa daga gwaji na lokaci-lokaci zuwa yawan amfani da miyagun ƙwayoyi da matsalolin da suka shafi sinadarai ( Robinson da Berridge, 1993 , 2003 ).

Wani wallafe-wallafen da suka daɗe suna nuna muhimmancin alaƙar da ke tsakanin tasirin magungunan ƙarfafawa da abubuwan da ke motsa jiki a muhalli a cikin neman magunguna da kuma sarrafa kai ( Stewart et al., 1984 ). Ikon haɗakar abubuwan da ke motsa ƙwayoyi don haifar da yanayin motsa jiki ( Stewart da Eikelboom, 1987 ) da sakin DA na gaba ( Aragona et al., 2009 ; Di Ciano et al., 1998 ; Duvauchelle et al., 2000 ; Ito et al., 2000 ) an tabbatar da shi sosai. Abu mai mahimmanci, abubuwan da ke motsa muhalli a baya sun haɗu da maganin psychostimulant a baya suna ɓacewa daga amsawa ga maganin ( Tran-Nguyen et al., 1998 ) da kuma dawo da neman magunguna ( de Wit da Stewart, 1981 ) ta hanyar da ta yi daidai da tasirinsu akan watsawar DA a cikin ƙwayoyin halittar ƙwayoyin halitta da amygdala ( Weiss et al., 2000 ). Ikon waɗannan abubuwan ƙarfafawa na dawo da neman ƙwayoyi yana dawwama ( Ciccocioppo et al., 2004 ) kuma yana ƙara ƙarfi da lokaci ( Grimm et al., 2001 ).

Saboda ana yin allurar magunguna akai-akai a gaban abubuwan da ke haifar da muhalli da yawa, yanayin ya isa ga ci gaban hankali da daidaita tasirin magungunan ƙarfafawa a lokaci guda, kuma waɗannan nau'ikan biyu na plasticity su yi hulɗa. Duk da cewa an san cewa hankali yana haɓaka ba tare da haɗin kai ba ( Singer et al., 2009 ; Vezina da Stewart, 1990 ), akwai shaidar cewa bayyanarsa na iya zama mai sarrafa ta hanyar abubuwan da ke haifar da muhalli waɗanda aka haɗa ko ba tare da haɗin kai da maganin ba ( Anagnostaras da Robinson, 1996 ; Anagnostaras et al., 2002 ; Stewart da Vezina, 1988 , 1991 ; Vezina da Leyton, 2009 ). Don haka, beraye da aka fallasa ga maganin a baya a cikin yanayi ɗaya suna nuna halayen da ke haifar da hankali a cikin wannan yanayi yayin da beraye da aka fallasa ga maganin a wasu wurare ba sa yin hakan. Hakika, beraye da suka taɓa karɓar maganin a wani wuri suna nuna matakan amsawa akan gwaje-gwaje don jin daɗi waɗanda suka yi daidai da na beraye da aka ba da maganin a karon farko. Ana iya yin amfani da wannan iko kan bayyana motsin rai na ɗabi'a, aƙalla don abubuwan da ke haifar da yanayi, ta hanyar aiki a cikin hippocampus na ventral - nucleus accumbens - ventral pallidum - ventral tegmental area neuronal madauki wanda ke daidaita harbin DA neuron a wurin ƙarshe ( Lodge da Grace, 2008 ).

Yawancin shaidun da ke nuna ikon abubuwan da ke motsa muhalli don sarrafa bayyanar da hankali sun fito ne daga gwaje-gwajen da ke auna motsi (a sama da nassoshi) kodayake an ruwaito irin wannan tasirin ga ƙwayoyin halittar da ke haifar da ƙwayoyin cuta DA over-flow ( Guillory et al., 2006 ; Reid et al., 1996 ). Abin mahimmanci, irin waɗannan abubuwan da ke haifar da muhalli waɗanda ke haifar da yanayi sun nuna cewa suna sarrafa bayyanar ingantaccen shan amphetamine da kuma dawo da shi da miyagun ƙwayoyi suka haifar a cikin beraye da suka taɓa fuskantar nicotine a baya ( Cortright et al., 2012 ), suna sake jaddada muhimmiyar rawar da waɗannan abubuwan ke takawa wajen bayyana ingantaccen shan ƙwayoyi da neman ƙwayoyi.

Duk da binciken da aka yi a sama kafin a fara aiki, an yi ta muhawara kan yadda ake amfani da su a fannin likitancin ɗan adam. Misali, babu wani canji ko ma raguwa da aka samu a martanin da aka bayar ga magunguna a cikin wasu bincike masu tasiri kan fallasa masu motsa jiki na psychostimulant da aka gudanar a cikin magungunan da ba na ɗan adam ba da kuma mutanen da suka kamu da cutar (misali, Bradberry, 2007 ; Volkow et al., 1997 ). Wannan ya haifar da shawarar cewa ƙaruwar amsawar DA da ke da alaƙa da jan hankalin miyagun ƙwayoyi yana da iyaka ga yanayin ɗan adam a matsayin hanyar amfani da miyagun ƙwayoyi da sauran nau'ikan cututtukan fata. Muna tantance fa'idodin wannan hujja a ƙasa ta hanyar yin bita kan sakamakon bincike da yawa da nufin gano tasirin magunguna da alamun da ke da alaƙa da miyagun ƙwayoyi a cikin mutane. Akwai dalilai da dama da suka bayyana waɗanda za su iya zama da mahimmanci don fahimtar yadda ake samar da halaye masu himma. Babban abu daga cikinsu shine kasancewar da rashin alamun da suka shafi jaraba da kuma ikonsu na daidaita martani ga magungunan da aka yi wa illa da sauran lada. Wannan lamari musamman zai iya sauƙaƙe haɗakar ƙungiyar binciken da ba ta da bambanci a baya a cikin adabin dabbobi da na ɗan adam.

3. Nazarin cikin mutane: jihohi da halayen halaye

3.1. Sakamakon ma'ana

A cikin masu shan miyagun ƙwayoyi, fallasa ga alamun da ke da alaƙa da magungunan ƙarfafawa yana haifar da martani iri-iri na ra'ayi, ɗabi'a da kuma ilimin halittar jiki ( Carter da Tiffany, 1999 ; Childress et al., 1988 ; O'Brien et al., 1990 ). Cewa waɗannan martanin suna kama da na miyagun ƙwayoyi ya yi daidai da ikonsu na haifar da yanayin ƙarfafawa da ke da alaƙa da maganin ( Stewart et al., 1984 ; Robinson da Berridge, 2003 ) 1.

Jihohin da aka yi amfani da su sun hada da takaitawa da mayar da hankali kan ladan da karuwar yaduwar mutane don bin da kuma kusanto masu. Hanyoyi masu mahimmanci masu alaƙa da aiki a cikin matsanancin yanayin ba lallai ba ne su kasance masu hankali (Fischman, 1989; Tiffany, 1990; Rago et al., 1991; Winkielman et al., 2005; Childress et al., 2008; Field et al., 2009; Perkins, 2009; Berridge, 2012; Waters et al., 2012); sha'awar sane na iya kusanci da dangantaka da aiki a cikin tsarin ginin gandun daji (Goldstein et al., 2009; de Lange et al., 2011). Ban da haka, sha'awar kai rahoton wakili ne da aka saba amfani da shi tare da kimantawa na ɗan lokaci wanda aka samu tare da bugun karen lantarki na lokaci-lokaci da ke tabbatar da cewa bayyanar lambobin miyagun ƙwayoyi, da haɓaka jihohin da ke sha'awar su, yawanci suna faruwa ne a cikin mintuna da awanni kafin sababbin abubuwa masu amfani da ƙwayoyi masu motsa jiki. (Epstein et al., 2009). Hakanan, a cikin nazarin dakin gwaje-gwaje, an ba da rahoton sha'awar da neman lada don ƙara yawan haɗari ga abubuwan da ke da alaƙa da amphetamine (Culbertson et al., 2010; Tolivar et al., 2010), cocaine (Childress et al., 1988, 1993), barasa (George et al., 2001; Bragulat et al., 2008), sigari (Droungas et al., 1995; Carter da Tiffany, 2001; Wray et al., 2011), heroin (Fatseas et al., 2011; Zhao et al., 2012a), da kuma ladan halitta kamar abinci (Jansen, 1998; Kelley da Berridge, 2002; Mahler da de Wit, 2010) da jima'i (Conaglen da Evans, 2006; Kim da Zauberman, a cikin manema labarai).

Alamu suna da tasiri mai ƙarfi idan mutane suka san cewa nan ba da jimawa ba za a sami damar amfani da maganin ( Carter da Tiffany, 2001 ; Dar et al., 2005 ; Juliano da Brandon, 1998 ). Waɗannan, ba shakka, su ne yanayi na yau da kullun da alamun ke bayyana a cikin muhallin halitta. An ba da rahoton wani misali mai ban mamaki na wannan abin da ya faru kwanan nan a cikin masu hidimar jirgin. Masu shan taba a kan gajeren lokaci (awanni 3-5.5) ko dogayen jira (awanni 8-13) sun haɓaka sha'awar sigari zuwa ƙarshen tafiyar. Sha'awar a ƙarshen ɗan gajeren tafiya ta yi ƙarfi kamar sha'awar a ƙarshen dogon jirgin kuma ta fi girma fiye da waɗanda aka gani a ɗan gajeren lokaci a lokacin dogon jirgin ( Dar et al., 2010 ).

Alamun da suka shafi magunguna na iya haifar da tasirin hali. Waɗannan sun haɗa da fifikon wuri mai kyau ( Children and de Wit, 2009 , a cikin manema labarai ) da kuma nuna son kai ( Cox et al., 2006 ; Hogarth et al. , 2008 ; Field et al. , 2009 ; Little et al., 2012 ), ƙarfafawa mai kyau ( Foltin da Haney, 2000 ), hanzarta fara amfani da miyagun ƙwayoyi ( Herman, 1974 ), da kuma ƙaruwar neman ƙwayoyi ( Panlilio et al., 2005 ; Hogarth et al., 2007 ) da kuma sarrafa kai ( Herman, 1974 ; Droungas et al., 1995 ; Mucha et al., 1998 ; Hogarth et al., 2010 ).

3.2. Tasirin magunguna

Kamar yadda aka tattauna a sama, wani babban wallafe-wallafen dabbobi ya nuna cewa yawan shan magungunan da aka yi amfani da su ba bisa ƙa'ida ba na iya canza tasirinsu. A cikin mutane, mafi kyawun canjin da aka gano bayan shan miyagun ƙwayoyi akai-akai shine haƙuri na ɗan lokaci ga tasirin abubuwan ƙarfafawa ( Brauer et al., 1996 ) da kuma tasirin damuwa na opiates da benzodiazepines ( Hug, 1972 ) 2. Idan aka kwatanta, an yi la'akari da yuwuwar cewa sha'awar miyagun ƙwayoyi na iya faruwa a cikin mutane ya fi rikitarwa. Shaidar farko ta fito ne daga lura da aka yi a Amurka da Japan bayan Yaƙin Duniya na Biyu a lokacin da aka yi amfani da magungunan kamar amphetamine. Tarihin baya-bayan nan daga wannan lokacin ya nuna cewa yawan shan amphetamines (yawanci 100 MG ko fiye) na iya haifar da alamun tabin hankali, gami da mafarki da ruɗi ( Connell, 1958 ; Ellinwood, 1967 ; Griffith et al., 1972 ; Sato, 1992 ; Sato et al., 1992 ). Ana iya sake haifar da waɗannan tasirin a cikin saitunan dakin gwaje-gwaje ( Angrist & Gershon, 1970 ; Bell, 1973 ). An gano cewa lokacin da ya kai ga farkon abin da ya faru na tabin hankali ya bambanta tsakanin mutane, wani tasiri mai yiwuwa yana da alaƙa da yawan shan magani, yawan amfani da shi, cin zarafin wasu abubuwa tare, da kuma kasancewar halayen rauni da suka riga suka kasance. Abin mamaki, an biyo bayan lokutan shan miyagun ƙwayoyi ga wasu mutane ta hanyar jinkirin sake bayyanar alamun tabin hankali bayan sake fallasa su ga ƙaramin allurai na maganin ( Sato, 1992 ; Sato et al., 1992 ).

Duk da cewa yana da ban sha'awa, rahotannin da ke sama ba su bayar da shaidar gwaji kai tsaye cewa yawan shan miyagun ƙwayoyi na iya haifar da abubuwan da ke kama da na hankali a cikin mutane ba. An bayar da rahoton wannan shaidar ne kawai kwanan nan. A cikin bincike shida daga cikin bakwai da aka gudanar a dakin gwaje-gwaje inda mahalarta suka sami aƙalla 20 mg (po) na d -amphetamine a kowace zaman, an lura da tasirin kuzari na maganin ( Tebur 1 ). A cikin binciken da aka yi kwanan nan, an kuma ga shaidar cewa wannan tasirin na iya kasancewa ƙarƙashin kulawar muhalli. Mutanen da suka karɓi allurai biyu na d -amphetamine a cikin ɗaki ɗaya sun ba da rahoton amsawar da aka samu ga allurar ta biyu yayin da waɗanda suka karɓi allurar ta biyu a cikin ɗaki daban-daban suka nuna, idan akwai wani abu, shaidar haƙuri ( Childs da de Wit, a cikin manema labarai ).

Table 1  

Dose-dogara ci gaban wayar da hankali ga maimaita d-amphetamine a cikin batutuwa na mutane masu lafiya.

Abin lura ne cewa lokutan da ake amfani da su wajen fahimtar juna da kuma irin wannan yanayin haƙuri sun bambanta . 3. Yayin da fahimtar juna abu ne mai ɗorewa, mai yiwuwa ma na dindindin ( Robinson da Becker, 1986 ; Boileau et al., 2006 ), haƙuri ya fi sauƙi ( Vogel et al., 1948 ; Hug, 1972 ; Brauer et al., 1996 ). Hakika, babban abin da ke haifar da yawan shan ƙwayoyi da mace-mace ya samo asali ne daga ikon da yanayin neman ƙwayoyi ke haifarwa bayan haƙuri ya ɓace ( Merrall et al., 2010 ).

3.3. Sakamakon ma'amaloli da cakulan + kwayoyi a cikin mahimmin yanki daban-daban

A cikin sassan da ke ƙasa, mun sake duba tasirin alamun magunguna da alamun da kwayoyi. Ana bincika waɗannan tasirin daban-daban a cikin mutane masu lafiya ba tare da jaraba ba, a cikin mutanen da ke cikin haɗarin jaraba, da kuma a cikin waɗanda ke da matsalolin amfani da miyagun ƙwayoyi. Bambanci tsakanin waɗannan al'ummomi yana da mahimmanci yayin da kwayoyi da alamun magani ke haifar da tasiri daban-daban a cikin mutane daban-daban. Tunda tasirin duka fallasa miyagun ƙwayoyi mai tsanani da maimaituwa na iya hulɗa da takamaiman halaye da mutum ke bayarwa, za su iya ba da haske game da abubuwan da ke tsara ci gaba da bayyana halayen da aka himmatu wajen samun da kuma shan magungunan cin zarafi da kansu. Hakika, kamar yadda aka saba gani, wasu daga cikin mutanen da ke gwada ƙwayoyi ne kawai ke haifar da matsalar amfani da miyagun ƙwayoyi ( Tsuang et al., 1998 ; Zinkernagel et al., 2001 ; Anthony, 2002 ; Agrawal et al., 2012 ; Kendler et al., 2012 ). Abubuwan da aka gano suna tasiri ga ci gaban jaraba sun haɗa da halayen mutum ( Ayduk et al., 2000 ; Conrod et al., 2000 ; Tarter et al., 2003 ), tarihin rayuwar farko ( Hyman et al., 2006 ; Enoch et al., 2010 ), ƙa'idodin zamantakewa da al'adu masu canzawa koyaushe ( Nutt, 2012 ), bambance-bambancen mutum a cikin enzymes na rayuwa na musamman na magunguna ( Ferguson da Tyndale, 2011 ), da ƙarin abubuwan gado tare da hanyoyin da ba a fayyace ba. Abin da waɗannan abubuwan lura ke nufi don nazarin hanyoyin da suka shafi jaraba da jaraba shine buƙatar gano da kuma bayyana tasirin da ka iya faruwa musamman a cikin wani rukunin mutane (duba Saunders da Robinson, wannan batu).

4. Batutuwa ba tare da jaraba ba: yunƙuri na kunnawa

4.1. Sakamakon ma'ana

Bayyanar abubuwan da suka shafi lada akai-akai yana kunna yanayin damuwa a cikin mutane masu lafiya ( Knutson da Cooper, 2005 ). An yi nazari sosai game da wannan dangane da lada ta kuɗi. A cikin waɗannan nazarin, an gabatar da nau'ikan abubuwan ƙarfafawa da yawa. Waɗannan sun haɗa da (i) alamomin da aka saba da su waɗanda waɗanda aka riga aka sani suna da alaƙa da kasancewar ko rashin lada, (ii) alamomin da ba su da tsaka-tsaki waɗanda waɗanda aka koya a baya yayin binciken, (iii) alamun da ke nuna cewa za a gabatar da lada ko dai bayan jira mara aiki ko bayan fitowar amsawar mai aiki, da kuma (iv) lada da kanta. Kowanne daga cikin waɗannan fasalulluka na iya shafar girman martanin tashin hankali da kuma ko an lura da shi musamman a cikin ventral ko dorsal striatum ( O'Doherty et al., 2004 ; Knutson da Cooper, 2005 ). Abin da aka mayar da hankali a kai a wannan bita shine yadda bambancin mutum da rukuni ke shafar girman waɗannan martanin tashin hankali.

Baya ga ladan kudi, an bayar da rahoton abubuwan da suka shafi lafiyar dan adam don nuna alamun raunin da ya biyo bayan fallasa abubuwan da suka shafi abinci (Etaramin et al., 2001; Beaver et al., 2006; Hommer et al., A cikin latsa; Demos et al., 2012; Tang et al., 2012), jima'i (Hamann et al., 2004; Cloutier et al., 2008; Demos et al., 2012), da barasa (Seo et al., 2011)4. Akwai wata shaidar cewa wadannan fMRI da aka auna na kwararar jini (CBF) na iya kasancewa hade da karuwa a cikin sakiwar DA (Box 1). Misali, zazzage DA fitarwa da aka auna a cikin batutuwa masu lafiya ta hanyar tomography na positron watsi (PET) na iya daidaitawa tare da ayyukan fMRI da aka auna (Schott et al., 2008). Abu mafi mahimmanci, an lura da shaidar DA saki a cikin batutuwa masu lafiya na mutane suna wasa wasannin bidiyo (Koepp et al., 1998) da kuma biyowa ga bayyanannan abubuwan da aka haɗu da su tare da lamuni na kuɗi (Zald et al., 2004; Schott et al., 2008; Martin-Soelch et al., 2011; cf, Hakyemez et al., 2008), abinci (Volkow et al., 2002; Etaramin et al., 2003), barasa (Yoder et al., 2009) da amphetamine (Boileau et al., 2007).

Box 1

A cikin 'yan shekarun da suka gabata, an ƙirƙiro manyan kayan aiki guda biyu don auna aiki a cikin kwakwalwar ɗan adam mai rai. A cikin nazarin aikin daukar hoton maganadisu mai aiki (fMRI), ana tantance ayyukan kwakwalwa na yanki ta hanyar auna canje-canje a cikin kwararar jinin kwakwalwa (CBF). Kamar yadda yake tare da dukkan kyallen halitta masu rai, ƙaruwar aiki yana buƙatar ƙaruwar kwararar jini don samar da iskar oxygen da ake buƙata. Siginar fMRI da aka kama da maganadisu suna amsawa ga canje-canje a cikin kwararar jini ta hanyar amfani da halayen paramagnetic da diamagnetic na deoxygenated da oxygenated hemoglobin, bi da bi. ƙudurin lokaci yana tsakanin 100 ms zuwa 2 s ya danganta da ko an ɗauki samfurin yanki ɗaya na kwakwalwa ko dukkan kwakwalwa. ƙudurin jiki yana tsakanin <1 zuwa 3 mm 3 , ya danganta da girman maganadisu ( Hernandez et al., 2001 ). Wannan hanyar ba ta da takamaiman ƙwayoyin cuta.

Ana iya amfani da hoton Positron emission tomography (PET) don auna aikin kwakwalwa, amma ya dogara ne akan ƙa'idodi daban-daban. Ana ba wa waɗanda abin ya shafa wani abu mai lakabin rediyoaktif wanda zai iya ketare shingen kwakwalwar jini. Mai gano lalacewa yana fitar da positrons waɗanda yawanci suna tafiya 0.2-7 mm kafin su haɗu da electron. Haɗarin yana samar da haskoki gamma waɗanda ke tafiya a cikin kwatancen da suka saba wa juna wanda ke haifar da kunna su a lokaci guda na na'urorin gano daidaituwa da aka sanya a kusa da kan wanda abin ya shafa. Siginar da aka sarrafa daga baya suna ba da bayanai game da girma tare da halayen lokaci da na sarari. Ruwan da aka yiwa alama yana ba da damar auna CBF. Amfani da masu gano alama kamar [ 11 C]raclopride (mai adawa da mai karɓar D2/3 DA) yana ba da damar kimanta samuwar masu karɓar D2/3 DA. Lokacin da aka ƙara matakan DA na waje, samuwar masu karɓar DA don [ 11 C]raclopride yana raguwa. Kodayake ƙudurin lokaci (minti 20 zuwa 30) da na anatomical (tsakanin cm 3 ) suna da sauƙi, hanyar an tabbatar da ita sosai ( Laruelle, 2000 ; Doudet da Holden, 2003 ).

Girman martanin DA da aka haifar da alamar na iya bambanta dangane da tabbacin da ake sa ran za a samu lada. Misali, a cikin dabbobin da ba na ɗan adam ba, ana ganin mafi girman ƙaruwa a cikin harbe-harben ƙwayoyin DA da aka haifar da lambar yabo a ƙarƙashin yanayin rashin tabbas mafi girma ( Fiorillo et al., 2003 ). Shaidar da aka samu kwanan nan ta nuna yiwuwar wannan tasirin rashin tabbas na iya faruwa a cikin mutane kuma: marasa lafiya da ke fama da cutar Parkinson suna nuna babban martanin DA da aka haifar da placebo idan aka sanar da su cewa damar karɓar maganin L-DOPA shine 75% idan aka kwatanta da 100% ( Lidstone et al., 2010 ) 5.

4.2. Sakamakon ma'anar + kwayoyi

Kamar yadda aka gani a cikin dabbobin dakin gwaje-gwaje, akwai shaida game da hulɗar juna tsakanin magunguna da alamomin da suka shafi lada tare da kowannensu yana daidaita martanin da ɗayan ke bayarwa ga ɗayan. A cikin mutanen da ke da lafiya, an lura da wannan a sarari a cikin bincike guda biyu inda tasirin dopaminergic na methylphenidate ya ƙaru ta hanyar kasancewar alamun sha'awa mai mahimmanci ( Volkow et al., 2002 , 2004 ). A cikin binciken farko, wanda aka gudanar a cikin mutanen da ke da lafiya waɗanda ba su da abinci (awa 16-20 na daina shan sa'o'i), haɗin ƙaramin kashi na methylphenidate (20 mg, po) da alamun abinci (gani, ƙanshi, ɗanɗano) ya haifar da sakin DA mai ƙarfi da kuma yunwar da aka ruwaito da kanta fiye da ko dai su kaɗai ( Volkow et al., 2002 ). Bambancin mutum ɗaya a cikin sakin DA ya danganta da yunwar da aka ruwaito da sha'awar abinci. A cikin binciken na biyu, methylphenidate (20 mg, po) ya haifar da sakin DA mai ƙarfi wanda za a iya aunawa kawai lokacin da aka haɗa shi da aikin lissafi mai mahimmanci wanda mahalarta zasu iya samun lada na kuɗi. Mafi girman sakin DA, mafi yawan batutuwa masu ban sha'awa sun ba da rahoton cewa aikin yana nan ( Volkow et al., 2004 ).

Wani bincike na uku ya bayar da gwaji na farko bayyananne ko shan magani akai-akai zai iya haifar da tasirin DA a cikin mutane ( Hoto na 1 ). An fallasa mutane masu lafiya ga allurai uku na d- amphetamine (0.3 mg/kg, po) a kowace rana. Bayan hutun makonni biyu, an ba da allurai na huɗu. Amsar DA ga wannan allurai na huɗu ya fi girma fiye da wanda aka bayar ta hanyar allurai na farko. Shawara ta biyar, wacce aka bayar shekara guda bayan haka, ta haifar da babban tasiri ( Boileau et al., 2006 ). Abin lura shi ne, duk allurai na d -amphetamine an ba su a cikin yanayi ɗaya (na'urar PET), wanda hakan ya sa sakamakon da aka samu ya yi daidai da yanayin da aka bayar. Duk da cewa wannan binciken bai tantance ko za a iya bayyana tasirin DA ba idan an ba da amphetamine a wani wuri, bincike biyu da aka gudanar kwanan nan a cikin masu amfani da magungunan ƙarfafawa marasa dogaro sun yi daidai da shawarar cewa kasancewar ko rashin abubuwan da ke da alaƙa da magani na iya yin tasiri ga girman martanin DA da miyagun ƙwayoyi suka haifar. A cikin binciken farko, an annabta bambance-bambancen mutum ɗaya a cikin ƙaruwar da cocaine ke haifarwa a cikin DA na waje ta hanyar tarihin rayuwa na amfani da miyagun ƙwayoyi masu ƙarfafawa a kan titi: mafi girman amfani da miyagun ƙwayoyi a baya, mafi girman martanin DA ( Cox et al., 2009 ). A cikin wannan binciken, mahalarta sun shirya, sarrafa su, kuma sun ba da maganin ta hanyar da suka saba. Wato, alamun da ke da alaƙa da cocaine sun kasance a bayyane kuma suna aiki da su. Idan aka kwatanta, a cikin wani bincike na biyu mai kama da haka, masu amfani da miyagun ƙwayoyi masu lafiya, waɗanda ba su dogara da su ba an ba su maganin d -amphetamine da aka ɓoye. A wannan yanayin, bambance-bambancen mutum ɗaya a cikin sakin DA yana da alaƙa mara kyau da amfani da miyagun ƙwayoyi: mafi girman amfani da miyagun ƙwayoyi a baya, ƙaramin martanin DA ( Casey et al., 2012 ). Tunda an yi amfani da irin wannan tasirin sosai a cikin binciken da aka gudanar a cikin dabbobin dakin gwaje-gwaje ( Anagnostaras da Robinson, 1996 ; Anagnostaras et al., 2002 ; Stewart da Vezina, 1988 , 1991 ; Vezina da Leyton, 2009 ), fassarar hasashe mai ban sha'awa game da waɗannan binciken ita ce kasancewar da rashin alamun magani daban-daban da na mahallin sun daidaita martanin ga abin da ke motsa magunguna ba tare da sharaɗi ba. Don haka, kasancewar alamun sakamako masu mahimmanci na iya ba da damar haɓaka dopaminergic don amsawa ga ƙalubalen magunguna; rashin irin waɗannan alamun na iya hana bayyanar ingantattun amsoshin DA.

Siffa 1  

Amphetamine-jawo DA hankali a cikin mutane. Koshin lafiya maza sun samu kashi biyar na d-amphetamine (0.3 mg / kg, po) yayin kwanciya a cikin na'urar sikirin PET. Ana gudanar da allurai uku na farko kowace rana ta biyu. Na huɗu kashi da aka ba bin a ...

4.3. Banbancin da suka shafi shekaru: abubuwan da suka shafi ci gaba

Wani wallafe-wallafen da ke fitowa suna jawo hankali ga bambance-bambancen da ke tsakanin amsawar motsin rai ga abubuwan da suka shafi lada a cikin matasa (shekaru 13-15) idan aka kwatanta da matasa (farkon shekarun 20). Misali, an ruwaito cewa matasa sun nuna ƙarfin motsa jiki fiye da manya lokacin da aka gabatar musu da wani abin ƙarfafawa wanda ke nuna damar amsawa don kuɗi ( Geier et al., 2010 ) kuma a martanin karɓar lada ( Ernst et al., 2005 ; Galvan et al., 2006 ). Bugu da ƙari, a tsakanin matasa, girman martanin motsin rai ga waɗannan alamu, mafi girman ƙimar halayensu na neman halaye da farin ciki da suka bayar da rahoton kansu ( Bjork et al., 2008a ) 6. An gabatar da waɗannan martanin da suka shafi shekaru don la'akari da bambance-bambancen ci gaba a cikin halayen ɗaukar haɗari da neman lada ( Spear, 2011 ; Ernst da Fudge, 2009 ; Somerville et al., 2010 ). Hakika, akwai shaida cewa waɗannan tasirin motsin rai suna da inganci na annabta. Misali, a tsakanin ɗaliban jami'a masu lafiya ( n = 58), girman ƙwayar halittar tana ƙara amsawa ga alamun abinci, yawan nauyin da ake samu a lokacin da aka biyo baya bayan watanni shida; girman martani ga alamun jima'i, yawan aikin jima'i yana ƙaruwa ( Demos et al., 2012 ).

5. Abubuwan da ke tattare da haɗari don jaraba: yunƙurin tashin hankali

Ana iya rarraba ƙungiyoyin mutane bisa ga haɗarin da suke da shi na jaraba. Daga cikin mafi kyawun masu hasashen abubuwa akwai (i) tarihin iyali mai yawa na matsalolin amfani da miyagun ƙwayoyi ( Dawson et al., 1992 ; Merikangas et al., 1998 ; Stoltenberg et al., 1998 ), (ii) bayyanar halayen ɗabi'a da kuma motsin rai, halayen neman halaye ( Krueger, 1999 ; Kendler et al., 1997 , 2003 , Tarter et al., 2003 ), da kuma (iii) martanin ra'ayi da ɗabi'a ga ƙalubalen ƙwayoyi ( Schuckit, 1980 ; de Wit da Phillips, 2012 ).

5.1. Sakamakon ma'ana

Wani ƙaramin littafi ya bayyana martani ga lada da alamun da suka shafi lada a cikin waɗanda ke cikin haɗarin kamuwa da cututtukan amfani da miyagun ƙwayoyi (duba Tebur 2 da ​da 3 ). Misali, idan aka kwatanta da kula da ƙarancin haɗari mai kyau, an lura da manyan martanin tashin hankali a cikin waɗanda ke cikin haɗarin iyali na shan giya yayin gudanar da Aikin Caca na Iowa ( Acheson et al., 2009 ) da kuma bayan fallasa ga warin barasa ( Kareken et al., 2004 ; Oberlin et al., 2012 ). Idan aka kwatanta, a cikin binciken da aka gabatar da alamun lada na kuɗi marasa sani ko kuma marasa tsaka-tsaki, yawan mutanen da ke cikin haɗari suna nuna ƙananan martanin tashin hankali fiye da kula da lafiya ( Andrews et al., 2011 ; Schneider et al., 2012 ; Yau et al., 2012 ).

Table 2  

fMRI GUDA BAYA NA GASKIYA an lura da darasin ɗan adam a gaban mutum da ba shi ladan da ke da alaƙa. Abubuwan da aka gabatar sune mutane da ke da saukin kamuwa da su, ko tare da rikicewar jaraba na yanzu.
Table 3  

PET [11C] martani na hanyar tashin hankali na fili da aka gani a cikin abubuwan da mutane suka gabatar a gaban sa kuma babu ladan da suka shafi alamomin. Abubuwan da aka gabatar sune mutane da ke da saukin kamuwa da su, ko tare da rikicewar jaraba na yanzu.

5.2. Sakamakon ma'anar + kwayoyi

Akwai shaida cewa tasirin magunguna da alamomin da ke da alaƙa da miyagun ƙwayoyi na iya yin mu'amala a cikin waɗanda ke cikin haɗarin kamuwa da jaraba. Misali, a cikin masu shan sigari marasa dogaro da shan sigari masu yawa, an gano cewa shan barasa yana ƙara yawan martanin tashin hankali ga alamun sigari ( King et al., 2010 ). Akasin haka, akwai shaida cewa alamun na iya ƙara tasirin magunguna. A cikin waɗanda ke da haɗarin kamuwa da jaraba, an ƙara martanin DA na striatal idan aka kwatanta da waɗanda ke da ƙarancin haɗari lokacin da aka sha maganin a cikin hanyar da aka saba ( Setiawan et al., 2010 ) amma ya ragu lokacin da aka ba da maganin ba tare da alamun da suka shafi magunguna ba ( Casey et al., 2012 ). Amsar da aka rage ta nuna halayen iyali da tasirin amfani da miyagun ƙwayoyi na baya: mafi girman tarihin rayuwa na amfani da miyagun ƙwayoyi, ƙaramin martanin DA ( Casey et al., 2012 ). Tasirin halayen iyali da amfani da miyagun ƙwayoyi na baya sun kasance masu zaman kansu. An nuna wannan ta hanyoyi biyu. Da farko, an haɗa ƙungiyar kulawa wadda ta ƙunshi maganin ƙarfafawa ta amfani da mutanen da suka yi amfani da miyagun ƙwayoyi ga mutanen da ke da haɗarin kamuwa da su amma ba su da tarihin iyali na matsalolin amfani da miyagun ƙwayoyi. Mutanen da ke da haɗarin kamuwa da su a cikin iyali waɗanda ke da tarihin iyali na matsalolin amfani da miyagun ƙwayoyi sun nuna ƙarancin sakin DA fiye da wannan maganin "ƙananan haɗari" wanda ke amfani da mutane marasa ƙwarewa a cikin rukuni ko kuma waɗanda ke da ƙwayar cuta. Na biyu, haɗa tarihin amfani da miyagun ƙwayoyi a matsayin mai yuwuwar canzawa a cikin nazarin ƙididdiga bai rage gudummawar tarihin iyali ba. Wato, tarihin amfani da iyali da miyagun ƙwayoyi sun samar da irin wannan tasiri amma sun yi aiki a matsayin masu ba da gudummawa masu zaman kansu.

6. Abubuwan da ke tattare da rikice-rikice na amfani da kayan maye: kunnawar tashin hankali

6.1. Sakamakon ma'ana

Abubuwan bincike guda biyu na kwanan nan na kwanan nan sun kammala da kansu cewa mahaɗa suna yin aiki akai-akai ta hanyar nunawa ga abubuwan da suka danganci miyagun ƙwayoyi a cikin batutuwa masu haɗuwa da ka'idojin bincike don amfanin cuta.s (Chase et al., 2011; Tang et al., 2012). TAmsar hese sun tabbata (Schacht et al., 2011) kuma ya daukaka, kamar yadda aka kwatanta da masu shan kwayoyi. Misali, idan aka kwatanta da masu saurin shaye na zamantakewar al'umma, an ba da rahoton masu shaye-shaye don nuna manyan abubuwan sa maye a cikin (Vollstädt-Klein et al., 2010; Ihssen et al., 2011): mafi girman saurin amsawa, mafi girman nuna fifiko na hankali (Vollstädt-Klein et al., 2011) da kuma mafi tsananin m-tilasta alamun bayyanar cututtuka (Vollstädt-Klein et al., 2010). Hakanan, a cikin babban binciken game da masu shan giya na 326, mafi girma da yawa na giya na haifar da tashin hankali, mafi girman matsalar matsalar amfani da giya (Claus et al., 2011)7.

Akwai shaida cewa ayyukan da ke sama na iya kasancewa tare da ƙaruwa a cikin sakin DA. An lura da canje-canje a cikin ƙimar ɗaurewar PET tracer wanda ke nuna sakin DA na striatal bayan fallasa ga alamun da ke da alaƙa da cocaine ( Volkow et al., 2006 ; Wong et al., 2006 ; Fotros et al., 2012 ) da heroin ( Zijlstra et al., 2008 ). Girman sakin DA da aka haifar da alama, mafi girman sha'awar ( Volkow et al., 2006 ; Wong et al., 2006 ; Zijlstra et al., 2008 ; Fotros et al., 2012 ).

Kamar yadda aka gani a wasu al'ummomi, akwai kuma shaida a cikin waɗanda ke da matsalar amfani da miyagun ƙwayoyi cewa ana rage tasirin motsa jiki maimakon ƙarawa idan alamun da suka shafi jaraba ba su nan. Idan aka kwatanta da waɗanda ke da iko, tasirin motsa jiki mai rauni yana faruwa ne sakamakon hotunan abinci a cikin masu shan giya ( Ihssen et al., 2011 ) da kuma alamun lada na kuɗi da ba a saba gani ba ko kuma marasa tsaka tsaki a cikin masu shan taba ( Peters et al., 2011 ) da masu shan giya da aka cire daga jiki ( Wrase et al., 2007 ; Beck et al., 2009 ; cf Bjork et al., 2008b ).

6.2. Sakamakon ma'anar + kwayoyi

A cikin mutanen da ke fama da matsalolin amfani da miyagun ƙwayoyi, an ruwaito cewa martanin DA na striatal da miyagun ƙwayoyi ke haifarwa ya ragu sosai idan aka kwatanta da waɗanda aka lura a cikin kula da lafiya ( Volkow et al., 1997 , 2007 ; Martinez et al., 2005 , 2007 , 2011 , 2012 ; Wang et al., 2012 ; Thompson et al., a cikin manema labarai ; cf Urban et al., 2012 ; duba Tebur 2 da 3).3 ). Waɗannan raguwar na iya ƙara ta'azzara hoton asibiti. Ƙananan martanin DA, mafi girman shan magungunan ƙarfafawa da aka lura a zaman daban-daban inda aka samar da maganin da alamun da ke da alaƙa ( Martinez et al., 2007 ) kuma mafi muni sakamakon asibiti a lokacin bin diddigin ( Martinez et al., 2011 ; Wang et al., 2012 ).

Abin lura, duk da haka, a cikin duk binciken da ke sama, an auna sakin DA ba tare da alamun magani ba. Wannan yana haifar da yuwuwar cewa, ko da a cikin jarabar mataki na ƙarshe, raguwar martanin DA da aka lura yana nuna, aƙalla a wani ɓangare, ko dai rashin abubuwan da ke da alaƙa da magani da ake buƙata don ba da damar bayyanar ingantaccen amsawar dopaminergic ko kasancewar abubuwan da ba a haɗa su da magani ba waɗanda ke iya hana wannan martanin ( Vezina da Leyton, 2009 ). Mun san wani bincike guda ɗaya kawai wanda ya gwada wannan hasashe a sarari. A cikin wannan binciken, an ba wa waɗanda suka dogara da cocaine amphetamine a zaman gwaji tare da ko ba tare da alamun magani ba (bidiyon 'yan wasan kwaikwayo suna kwaikwayon amfani da miyagun ƙwayoyi). Idan aka kwatanta da zaman gwajin da aka gudanar ba tare da alamun magani ba, kasancewar alamun magani a zahiri ya rage martanin DA gaba ( Volkow et al., 2008 ), wani tasiri akasin abin da marubutan suka annabta. Duk da haka, wannan lura yana ƙara wa shaidar cewa alamun muhalli na iya daidaita tasirin magunguna na ƙalubalen magungunan ƙarfafawa. Bugu da ƙari, kamar yadda marubutan suka lura, tunda alamun ba su yi hasashen gaske cewa magani zai samu ba, akwai yiwuwar an sami kuskuren hasashen lada da ke da alaƙa da raguwar sakin DA ( Schultz et al., 1997 ; Yoder et al., 2009 ). Duk da haka, wannan fassarar ta ci gaba da kasancewa mai hasashe har sai an ba da rahoton ƙarin bincike da ke gwada shawarar a sarari. Sauran abubuwan da ka iya haifar da raguwar sakin DA da aka fitar daga miyagun ƙwayoyi a cikin al'ummomin da suka dogara da sinadarai sun haɗa da tasirin neurotoxic na yawan amfani da miyagun ƙwayoyi ( Little et al., 2003 , 2009 ) da halayen haɗari da suka riga suka kasance ( Casey et al., 2012 ). Iyakokin hanyoyin na iya zama masu dacewa. Kamar yadda Narendran da Martinez suka lura (2008) , raguwar amsawar dopaminergic na iya nuna raguwa a cikin kusancin mai karɓar D2 ko D3 DA, raguwa a cikin rabo na masu karɓar D3 zuwa D2 DA, ko ƙaruwa a cikin matakan DA na asali na hutu. Ko da yake, ƙoƙarin farko na magance wasu daga cikin waɗannan damar, ya nuna cewa masu shan ƙwayoyi masu motsa jiki, waɗanda aka gwada a ƙarƙashin yanayi iri ɗaya kamar yadda aka yi a cikin binciken da ke sama, suna da ƙananan matakan hutawa na DA maimakon mafi girma ( Martinez et al., 2009 ) kuma mafi girma maimakon ƙananan matakan masu karɓar D3 DA aƙalla a cikin yankunan kwakwalwa masu arzikin masu karɓar D3 DA kamar midbrain da globus pallidus ( Boileau et al., 2012 ).

7. Abubuwan da ke cikin abubuwan da ba a amfani da su ba - caca da raunin cin abinci mai ƙarfi: Ayyukan tashin hankali

An gabatar da cewa caca ( Frascella et al., 2010 ; Leeman da Potenza, 2012 ) da kuma matsalolin cin abinci mai yawa 8 ( Davis et al., 2011 ; Gearhardt et al., 2011 ) nau'ikan jaraba ne. Dukansu ƙungiyoyin suna cikin haɗarin kamuwa da cututtukan shan ƙwayoyi, duk da haka wasu daga cikin mutanen da abin ya shafa ba sa shan ƙwayoyi ko barasa sosai. Nazarin da aka yi a waɗannan al'ummomin da ke da jarabar da ba ta da sinadarai don haka suna da yuwuwar haskaka hanyoyin da suka dace da halayen neman lada da ke damun su a ware daga tasirin da kwayoyi da kansu ke samarwa.

A cikin nazarin fMRI, an lura da ƙaruwar kunna bugun jini a cikin masu caca masu matsala, idan aka kwatanta da waɗanda ba 'yan caca ba, bayan fallasa su ga katunan wasa da ke da alaƙa da ladan kuɗi ( van Holst et al., 2012 ). Sabanin haka, ko dai an rage girman martanin bugun jini ( Balodis et al., 2012 ; Miedl et al., 2012 ; cf Reuter et al., 2005 ) ko kuma martanin bugun jini na yau da kullun ( de Ruiter et al., 2009 ) an ruwaito su bayan fallasa su ga alamun ladan kuɗi da ba a saba gani ba ko kuma tsaka tsaki (duba Tebur 2 da ​da ​33 ).

Sakamakon binciken PET [ 11 C]raclopride ya nuna cewa martanin DA na striatal DA sun bi irin wannan tsari. Misali, an lura da karuwar martanin DA na striatal ga (i) aikin caca na gaske a cikin marasa lafiya da ke fama da caca mai tsanani ( Joutsa et al., 2012 ), (ii) alamun caca da aka saba da su da L-DOPA a cikin marasa lafiya da ke fama da cutar Parkinson da kuma caca ta hanyar jima'i ( Steeves et al., 2009 ), (iii) abubuwan da ke haifar da abinci da aka gabatar wa masu cin abinci mai yawa ( Wang et al., 2011 ), (iv) Maganin L-DOPA da aka bai wa marasa lafiya da ke fama da cutar Parkinson wadanda ke nuna matsalolin sarrafa sha'awa daban-daban ( Evans et al., 2006 ; O'Sullivan et al., 2011 ), da kuma (v) shan kwayoyin d -amphetamine ba tare da ɓoye ba ga masu caca ( Payer et al., 2012 ). Idan aka kwatanta, an lura da martanin DA na striatal da aka yi wa rauni bayan ƙalubalen magungunan ƙarfafawa da aka bayar ba tare da alamun magani ba ga marasa lafiya da ke fama da bulimia nervosa ( Broft et al., 2012 ). Abin lura ne cewa, ƙarin martanin DA na iya ƙara ta'azzara hoton asibiti. Masu caca da ke nuna mafi girman sakin DA na striatal suna da mafi girman maki na tsananin asibiti ( Joutsa et al., 2012 ), mafi girman wahalar hana caca ( Payer et al., 2012 ), da kuma ƙarancin maki a kan Aikin Caca na Iowa ( Linnet et al., 2010 , 2011 ).

8. Lusarshe: magance zallar - haɓaka ko toshewa?

Addiction akwai hadaddun, masana'antu da yawa, da kuma maganganu iri-iri cikin asali da magana. Abubuwan da aka tattauna a cikin bita na yanzu ba za su iya yin la'akari da kowane ɓangaren cutar ba. A matakin neurobiological kadai, jaraba sun ƙunshi ƙarin yankunan kwakwalwa fiye da tashin hankali da ƙarin ƙwaƙwalwar ƙwayoyi fiye da DA. Ban da haka, Ra'ayin na yanzu yana bayanin hanyoyin da zasu iya yin yawaitar yawancin bambance-bambancen a cikin wallafe-wallafen. Hakanan zai iya haɓaka fahimtarmu game da rawar da ke tattare da abubuwan shaye shaye a cikin illolin cutar etiology, hanya da sakamako.

Binciken da aka yi nazari a sama ya nuna cewa, a cikin mutane, sake fallasa ga abubuwan da ke motsa jiki masu ƙarfi na iya haifar da martanin ɗabi'a da na jijiyoyi. Yayin da fallasa ke ƙaruwa, waɗannan alamun kuma na iya daidaita martani ga lada da kansu. Yawan kunna wutar lantarki na iya faruwa lokacin da lada da alamun da suka shafi lada suke. Rashin kunna wutar lantarki na iya faruwa lokacin da alamun da aka haɗa lada ba su nan. Bayyana ga lada a gaban alamun da ke da alaƙa da lada na iya haifar da tasirin haɗin gwiwa, wani abu da ya faru a lokaci guda wanda har zuwa yau ya fi yawa a kan titi fiye da dakin gwaje-gwaje. A ƙarshe, sakamakon da aka yi bita a nan ya nuna cewa waɗannan hanyoyin da aka tsara na iya yin tasirinsu ba kawai a farkon matakan amfani da ƙwayoyi ba amma har ma suna ci gaba da yin hakan a lokacin matakan jaraba na gaba.

Wadannan tasirin tasirin suna sama da fifikon ilimi. Na farko, yanayin dogaro, yanayin kwantar da hankali na tsarin karfafa gwiwa na iya lissafi a babban bangare don karuwar tuki don samun wasu lada da kuma rage tuki don samun wasu, abubuwan da suka shahara a matsayin abubuwan maye. Na biyu, idan hanyoyin da aka gabatar suka ci gaba da samun tasirin iri ɗaya da zarar an tsaida abubuwan kara kuzari, to ƙirar ma tana da tasirin magani. Misali, an yi kokarin da yawa don toshe wani tsarin da aka dauka na DA (mai hankali). Kodayake dabarar ba ta ƙare ba, makafi-biyu, jarabawar asibiti mai kulawa da ƙwaƙwalwar ƙwaƙwalwar ƙwayar cuta ba ta tabbatar da tasiri ba (Grabowski et al., 2000; Kampman et al., 2003; Smelson et al., 2004; Reid et al., 2005). A madadin haka, ƙara yawan watsawar DA shine mafi yawan yiwuwar sake komawa cikin aiki (de Wit, 1996; Barrett et al., 2006). Kowane ɗayan waɗannan dabarun a cikin kadaici na iya rasa ingantaccen aikin asibiti saboda marasa lafiya da masu jaraba suna dandana lokatai na ƙara da raguwa tashin hankaliSiffa 2). Zai iya inganta dabarun ingantawa ta hanyar hanyoyin da za su iya inganta ingantaccen martani game da miyagun ƙwayoyi da kuma ikon sarrafawa ta hanyar ƙwayoyin da ke haɗuwa da ƙwayoyi (Kim et al., 2005; Barrett et al., 2008; Venugopalan et al., 2011; Loweth et al., 2013) ko wajan jure wa marassa lafiyar zuwa hango wasu bukatu da lada, kamar yadda aka samu yayin horo na son zuciya (Attwood et al., 2008; Fadardi da Cox, 2009; Schoenmakers et al., 2010; Zhao et al., 2012b) da kuma hanyoyin kulawa da kulawa na gaba (Dutra et al., 2008; Volpp et al., 2009). Sakin jinkirin DA shirye-shiryen agonist na kai tsaye sun nuna daidaito, kodayake ba a dace ba, inganci a wasu alƙaluma (Castells et al., 2010; Mariani et al., 2012). Masu zaɓar masu karɓar masu karɓar DA D3 da masu kula da DA suna cikin haɓaka, kuma yana iya tabbatar da taimako (Mugnaini et al., 2012; cf, Dodds et al., 2012).

Siffa 2  

Model na striatal kunnawa cikin jaraba. Marasa lafiya na iya fuskantar lokuttan tsoratarwa da tsotsar tsotsar zuciya dangane da kasancewar gaban abubuwan da suka shafi yanayin jaraba. A cikin wannan samfurin, ana tsinkayar jiyya na ƙwaƙwalwar ƙwayar cuta ...

A ƙarshe, shaidar da ta gabata ta ɗaga yiwuwar cewa bambance-bambancen mutum a cikin mai saurin ɗauka don sanya ƙima mai mahimmanci don lada da alaƙa waɗanda ke da alaƙa da kasancewa mai ma'ana da tasiri, yana haifar da yanayin cutarwar game da jaraba ko lalata wata sabuwar hanyar haɗarin ƙwaƙwalwar ƙwayar cuta (Flagel et al., 2011; Fotros et al., 2012; Mahler da de Wit, 2010; Saunders da Robinson, wannan batun). A ƙarshen batun, DA maganin da aka yi niyya zai iya amfana da ƙimar sub mai amfani da DA ta hanyar rarrabuwa. Yayi daidai da masaniyar cewa tasirin kunnawa yana nuna halayen da ake da su, ana bambance bambance-bambance na mutum a cikin lada daban-daban da halayen dabi'un ta hanyar girman fMRI BOLD (Beaver et al., 2006; Bjork et al., 2008a) Da DA martani (Leyton et al., 2002; Boileau et al., 2003, 2006; Buckholtz et al., 2010a,b; Treadway et al., 2012). Alamar DA ta bayyana suna da mahimmancin halayyar. Rage watsa watsa DA yana rage sha'awar kwalliyar cocaine (Berger et al., 1996; Leyton et al., 2005), hankali ga akasin magunguna (Franken et al., 2004; Munafó et al., 2007; Hitsman et al., 2008),, halayyar sakamako guda biyu hade da lambobin don bayyana fintiren amsawa (Leyton et al., 2007), da kuma shirye don aiki don magani (Barrett et al., 2008; Venugopalan et al., 2011da kuma ladan kudi ()Cawley et al., 2010). Wadannan lura sun yi daidai da ra'ayin cewa an karu maimakon rage DA watsawa wanda ke haskaka abubuwan da ake amfani da su na miyagun ƙwayoyi, abubuwan da aka gani kwanan nan a duk fa'idodin amfani da kayan maye.Venugopalan et al., 2011). Saboda haka, gano hanyoyin da za a canza waɗannan martaban da DA a hanyar warkewa ta ragu, za mu ba da shawara, muhimmiyar maƙasudin asibiti.

Acknowledgments

An yi wannan bita ta hanyar tallafin daga Makarantun Kanada don Binciken Kiwon Lafiya (MOP-36429 da MOP-64426, ML) da kuma Cibiyoyin Lafiya na Kasa (DA09397, PV). Mun sadaukar da wannan bita ga Ann Kelley. Energyarfin ƙarfinta, ƙaunar rayuwa, da zurfin ilimi da sha'awar aikinta sun sa ta zama abin koyi ga dukkanmu.

Bayanan kalmomi

1 Ƙarfafawa da ke da alaƙa da opiates da ethanol suna haifar da haɗuwa mai rikitarwa na tasirin magunguna da akasin magunguna ( Wikler, 1973 ; Eikelboom da Stewart, 1982 ; Stewart et al., 1984 ; O'Brien et al., 1998 ; Stewart, 2004 ). Don tattaunawa kan yadda yanayin ƙarancin abinci zai iya ƙara yanayin ƙarfafawa da kuma yanayin sha'awar abinci, duba Toates (1986) , Hutcheson et al. (2001) , da Berridge (2012) . An kuma gabatar da rawar da yanayin dysphoric ke takawa wajen kula da amfani da abubuwan ƙarfafawa a cikin ra'ayoyin abokan hamayya game da shan miyagun ƙwayoyi ( Koob da Le Moal, 1997 ). Waɗannan yanayin galibi ana lura da su jim kaɗan bayan tsawaitawa da ci gaba da shan ƙwayoyi, amma an kuma gabatar da shawarar haifar da su ta hanyar alamun da aka tsara don taimakawa wajen sake dawowa ( Siegel, 1979 ).

2 Juriyar Magunguna tana nufin raguwar ƙarfin magani ko ingancinsa (watau, mafi girman tasirinsa) tare da sake fallasa shi. Akasin haka, ji, wanda aka yiwa lakabi da jurewa baya, yana nufin ƙaruwar ƙarfin magani ko inganci (wani lokacin ana nuna shi azaman babban martani ga allurar da ba ta da tasiri a baya). Duk waɗannan kalmomin suna bayyana abubuwan da aka lura a zahiri; a cikin kansu ba sa nuna tsarin aiki.

3 Duk da bambance-bambancen lokutan da ake amfani da su don haƙuri da fahimtar juna, akwai yiwuwar haɗuwa ta lokaci-lokaci domin kowanne daga cikin waɗannan daidaitawar na iya faruwa a lokaci guda a cikin tsarin daban-daban, kamar, misali, waɗanda ke daidaita numfashi idan aka kwatanta da waɗanda ke motsa motsin rai.

4 Ƙunƙwasawa na striatal kuma na iya faruwa bayan asarar kuɗi ( Kühn et al., 2011 ). A cikin wannan binciken, mahalarta 'yan wasan bidiyo ne 'yan shekara 14 masu shekaru 154. 'Yan wasan da suka saba (> awanni 9 a mako) sun nuna babban martanin striatal ga asarar kuɗi kamar yadda aka auna ta hanyar aikin hoton maganadisu mai aiki (fMRI) idan aka kwatanta da 'yan wasan da ba sa yawan yin striatal. Abin lura shi ne, abubuwan da ke nuna asara suna da matuƙar muhimmanci ga 'yan wasa. Daga cikin ƙwararrun 'yan wasa, babban kunnawa na striatal kuma yana annabta saurin motsi, wani tasiri mai yiwuwa yana nuna haɓaka ikon alamun don shiga hanyoyin kusanci ( Wan et al., 2011 ).

5 Waɗannan yanayi na isar da lada mara tabbas suna kwaikwayon wani muhimmin al'amari na caca. Bugu da ƙari, a cikin beraye, isar da lada mara tabbas na iya ƙara ƙarfin ƙarfafawa na alama ( Robinson da Berridge, 2012 ) kuma yana haifar da fahimtar ɗabi'a ga ƙalubalen amphetamine ( Singer et al., 2012 ).

6 Akwai kuma yanayi idan aka lura da ƙananan martanin tashin hankali, kodayake sakamakon da aka ruwaito zuwa yanzu yana da rikitarwa kuma abubuwan da suka dace ba su bayyana ba. Misali, an lura da ƙananan martanin tashin hankali a cikin matasa da manya suna kimanta alama kafin su iya amsawa ( Geier et al., 2010 ). Hakazalika, yayin da matasa ke nuna manyan martani fiye da manya ga lada ( Ernst et al., 2005 ; Galvan et al., 2006 ), an ruwaito cewa ribar amsawar tashin hankali tsakanin manyan lada ($ 5 idan aka kwatanta da 20 cents) ya ragu ( Bjork et al., 2004 ). Wani fassarar ita ce matasa suna nuna manyan martanin tashin hankali ga lada da lada da aka haɗa amma ƙananan martani ga ƙarin alamun nesa da ke buƙatar ƙarin hanyoyin kimantawa.

7 Wani bincike na baya-bayan nan ya nuna yadda ƙaruwa da raguwar ayyukan motsa jiki na iya bambanta tare da halayen neman ƙwayoyi da jaraba. Wani majiyyaci mai tsananin shan giya ya sami zaman motsa jiki na maganadisu na transcranial (TMS) na dorsal anterior cingulate cortex. An auna aikin kwakwalwa na yanki da kuma sha'awar da kansa ya bayar a lokaci guda. Kamar yadda aka zata, sha'awar da barasa ta haifar ta danganta da ƙaruwar aiki a cikin ƙwayoyin halittar. Abin mamaki, TMS ta rage sha'awar da kunna ƙwayoyin halittar ƙwayoyin halittar, tasirin da aka kiyaye na tsawon watanni uku ( De Ridder et al., 2011 ).

8 Matsalolin cin abinci mai yawa suna da siffofi daban-daban na yau da kullun tare da matsalolin amfani da miyagun ƙwayoyi da caca. Neman lada mara kyau, rashin kulawa da motsin rai, da sauran jaraba iri-iri galibi suna tare da juna. An kuma gabatar da cewa kiba wani nau'i ne na jarabar ɗabi'a, kodayake wannan ra'ayin ya fi kawo ce-ce-ku-ce. Don tattaunawa kan waɗannan batutuwa, duba Ziauddeen et al. (2012).

References

  1. Acheson A, Robinson JL, Glahn DC, Lovallo WR, Fox PT. Bambancin kunnawa na ciki cingulate cortex da caudate nucleus yayin wasan kwaikwayo na caca a cikin mutane tare da tarihin iyali na barasa: karatu daga Oklahoma Family Health Patrums Project. Magunguna da Shan Giya. 2009; 100: 17 – 23. [PMC free article] [PubMed]
  2. Agrawal A, Verweij KJH, Gillespie NA, Heath AC, Lessov-Schlaggar CN, Martin NG, Slutske WS, Whitfield JB, Lynskey MT. Halittar ilimin jaraba — buri ne. Fassarar ƙwaƙwalwa. 2012; 17 (2): e140. [PMC free article] [PubMed]
  3. Anagnostaras SG, Robinson TE. Sensitization ga psychomotor stimulant sakamakon amphetamine: daidaito ta hanyar koyon hadin kai. Harkokin Nunin ƙwaƙwalwa. 1996; 110: 1397 – 1414. [PubMed]
  4. Anagnostaras SG, Schallert T, Robinson TE. Processeswayoyin ƙwaƙwalwar ajiya suna jagoranci amphetamine-jawo hankalin psychomotor. Neuropsychopharmacology. 2002; 26: 703 – 715. [PubMed]
  5. Andrews MM, Meda SA, Thomas AD, Potenza MN, Krystal JH, Worhunsky P, Stevens MC, O'Malley S, Littafin GA, Reynolds B, Pearlson GD. Kowane ɗayan tarihin dangi don shaye shaye yana nuna aikin nuna hoto mai banbanci a cikin sakamako mai laushi wanda ke da alaƙa da abubuwan rashin hankali. Ilimin halayyar dan adam. 2011; 69: 675 – 683. [PMC free article] [PubMed]
  6. Angrist BM, Gershon S. Tarihin gwaji ya jawo hankalin amphetamine psychosis - bayanan kallo na farko. Ilimin halayyar dan adam. 1970; 2: 95 – 107. [PubMed]
  7. Anthony JC. Epidemiology na dogaro da ƙwayoyi. A cikin: Davis KL, Charney D, Coyle JT, Nemeroff C, masu gyara. Neuropsychopharmacology: Zamani na Biyar na Ci gaba. Lippincott Williams & Wilkins; Philadelphia: 2002. shafi na 1557-1574.
  8. Aragona BJ, Rana JJ, Roitman MF, Cleaveland NA, Wightman M, Carelli RM. Specificayyadaddun yankuna a cikin ainihin-lokacin haɓaka matakan fatattaka na dopamine lokacin cinikayyar ƙungiyar cca-cocaine a cikin beraye. Jaridar Turai ta Nazarin ilimin halittar kwakwalwa. 2009; 30: 1889 – 1899. [PMC free article] [PubMed]
  9. Attwood AS, O'Sullivan H, Leonards U, Mackintosh B, Munafo MR. Horar da hankali da nuna azama a cikin masu shan sigari. Addua. 2008; 103: 1875 – 1882. [PubMed]
  10. Ayduk O, Mendoza-Denton R, Mischel W, Downey G, Peake PK, Rodriguez M. Jagoran kai tsaye: tsarin kulawa da kai na musamman don jimre wa abin da yake so. Jaridar mutum da ilimin halayyar dan adam. 2000; 79: 776 – 792. [PubMed]
  11. Balodis IM, Kober H, Worhunsky PD, Stevens MC, Pearlson GD, Potenza MN. Rage ayyukan gaba a yayin aiwatar da ladan kudi da asarar kudi a caca. Ilimin halayyar dan adam. 2012; 71: 749 – 757. [PMC free article] [PubMed]
  12. Barrett SP, Pihl RO, Benkelfat C, Brunelle C, Matashi SN, Leyton M. Matsayi na dopamine a cikin gudanarwar giya a cikin mutane: bambance-bambancen mutum. Turai Neuropsychopharmacology. 2008; 18: 439 – 447. [PubMed]
  13. Barrett SP, Tichnauer M, Leyton M, Pihl RO. Nikotine yana ƙara yawan shan barasa a cikin masu shan sigari. Magunguna da Shan Giya. 2006; 81: 197 – 204. [PubMed]
  14. Beaver JD, Lawrence AD, van Ditzhuijzen J, Davis MH, Woods A, Calder AJ. Kowane ɗayan banbanci a cikin sakamako yana ba da izinin amsawa ga yanayin abinci. Jaridar Neuroscience. 2006; 26: 5160 – 5166. [PubMed]
  15. Beck A, Schlagenhauf F, Wüstenberg T, Hein J, Kienast T, Kahnt T, Schmack K, Hägele C, Knutson B, Heinz A, Goge J. Ventral striatal kunnawa yayin ladabtarwa yana da dangantaka da sha'awar giya. Ilimin halayyar dan adam. 2009; 66: 734 – 742. [PubMed]
  16. Bell DS. Gwajin gwaji na psychophis na amphetamine. Sanarwa na Janar Psychiatry. 1973; 29: 35 – 40. [PubMed]
  17. Berger SP, Hall S, Mickalian JD, Reid MS, Crawford CA, Delucchi K, Carr K, Hall S. Haloperidol antagonism na cue-elicited cocaine craving. Lancet. 1996; 347: 504 – 508. [PubMed]
  18. Berridge KC. Daga kuskuren hasashen izuwa ga sakamako mai ƙarfi: lissafin mesolimbic na motsawar sakamako. Jaridar Turai ta Nazarin ilimin halittar kwakwalwa. 2012; 35: 1124 – 1143. [PMC free article] [PubMed]
  19. Bjork JM, Knutson B, Fong GW, Caggiano DM, Bennett SM, Hommer DW. Gudanar da kwakwalwa mai saurin sauraro cikin samari: kamanceceniya da banbanci daga samari. Jaridar Neuroscience. 2004; 24: 1793 – 1802. [PubMed]
  20. Bjork JM, Knutson B, Hommer DW. Centirƙiri mai ɗaukar lamuni ya kunna cikin yaran masu giya. Addua. 2008a; 103: 1308 – 1319. [PubMed]
  21. Bjork JM, Smith AR, Hommer DW. Jigilar yanayin tsufa don ba da lada ga isar da aiki da raɗaɗin marasa lafiya a cikin abubuwan dogaro na marasa lafiya. NeuroImage. 2008b; 42: 1609 – 1621. [PMC free article] [PubMed]
  22. Boileau I, Assad JM, Pihl RO, Benkelfat C, Leyton M, Diksic M, Tremblay RE, Dagher A. Alcohol yana inganta sakin dopamine a cikin ƙimar ɗan adam. Synapse. 2003; 49: 226 – 231. [PubMed]
  23. Boileau I, Dagher A, Leyton M, Gunn RN, Baker GB, Diksic M, Benkelfat C. Yin kwaikwayon kwaikwayo don ƙarfafawa a cikin mutane: A [11C] nazarin raclopride / PET a cikin masu ba da agaji na lafiya. Sanarwa na Janar Psychiatry. 2006; 63: 1386 – 1395. [PubMed]
  24. Boileau I, Dagher A, Leyton M, Welfeld K, Booij L, Diksic M, Benkelfat C. Sakin yanayi na dopamine a cikin mutane: A PET [11C] nazarin raclopride tare da amphetamine. Jaridar Neuroscience. 2007; 27 (15): 3998 – 4003. [PubMed]
  25. Boileau I, Payer D, Houle S, Behzadi A, Rusjan PM, Tong J, Wilkins D, Selby P, George TP, Zack M, Furukawa Y, McCluskey T, Wilson AA, Kish SJ. Babban ɗawainiyar dopamine D3 mai karɓa-fi so ligand [11C] - (+) - propyl-hexahydro-naptho-oxazin a cikin masu amfani da ƙwayoyin polydrug na methamphetamine: nazarin positron watsi tomography. Jaridar Neuroscience. 2012; 32: 1353 – 1359. [PMC free article] [PubMed]
  26. Bradberry CW. Tsarin fahimta na Cocaine da tsinkayen dopamine na tasirin tasirin a cikin jijiyoyi, birai, da mutane: Yankunan yarjejeniya, rashin jituwa, da abubuwan da ke haifar da jaraba. Psychopharmacology. 2007; 191: 705 – 717. [PubMed]
  27. Bragulat V, Dzemidzic M, Talavage T, Davidson D, O'Connor SJ, Karaken DA. Alkahol na lura da martanin da ke cikin ƙwayar cuta ga kamshi na giya mai ban sha'awa: nazarin fMRI. Alcoholism: Clinical da Gwajin Nazari. 2008; 32: 1124 – 1134. [PMC free article] [PubMed]
  28. Brauer LH, Ambre J, de Wit H. Babban haƙurin haƙuri amma ba tasirin cututtukan zuciya na d-amphetamine a cikin al'ada, maza masu lafiya. Jaridar Clinical Psychopharmacology. 1996; 16: 72 – 76. [PubMed]
  29. Braus DF, Wrase J, Grüsser S, Hermann D, Ruf M, Flor H, Mann K, Heinz A. Alkahol da ke da alaƙar motsa jiki suna kunna gurnar giya a cikin masu maye. Jaridar watsa labaran Neural. 2001; 108: 887 – 894. [PubMed]
  30. Broft A, Shingleton R, Kaufman J, Liu F, Kumar D, Slifstein M, Abi-Dargham A, Schebendach J, Van Heertum R, Attia E, Martinez D, Walsh BT. Dopamine mai wahala a cikin bulimia nervosa: nazarin hoto na PET. Jaridar kasa da kasa ta Rashin Tsarin Abinci. 2012; 45 (5): 648 – 656. [PMC free article] [PubMed]
  31. Buckholtz JW, Treadway MT, Cowan RL, Woodward ND, Benning SD, Li R, Ansari MS, Baldwin RM, Schwartzman AN, Shelby ES, Smith CE, Cole D, Kessler RM, Zald DH. Tsarin sakamako na Mesolimbic dopamine yana haifar da rashin kwanciyar hankali a cikin mutane tare da halayen psychopathic. Yanayin Neuroscience. 2010a; 13: 419 – 421. [PMC free article] [PubMed]
  32. Buckholtz JW, Treadway MT, Cowan RL, Woodward ND, Li R, Ansari MS, Baldwin RM, Schwartzman AN, Shelby ES, Smith CE, Kessler RM, Zald DH. Dopaminergic cibiyar sadarwa bambance-bambance a cikin ɗan adam. Kimiyya. 2010b; 329: 532. [PMC free article] [PubMed]
  33. Carter BL, Tiffany ST. Meta-bincike na cue-reactivity a cikin binciken jaraba. Addua. 1999; 94: 327 – 340. [PubMed]
  34. Carter BL, Tiffany ST. Misalin abubuwan amfani: sakamakon shan sigari a kan sake amfani da sigari a cikin masu shan sigari. Gwaji da Clinical Psychopathology. 2001; 9: 183 – 190. [PubMed]
  35. Casey KF, Benkelfat C, Cherkasova MV, Baker GB, Dagher A, Leyton M. Attenuated amphetamine-induced dopamine saki a cikin batutuwa a cikin hadarin iyali don haɗarin abubuwa. 10th International Catecholamine Symposium.2012.
  36. Castells X, Casas M, Pérez-Maná C, Roncero C, Vidal X, Capellà D. Ingancin magungunan psychostimulant don dokin maye. Dandalin Cochrane. 2010; 3: 1 – 206.
  37. Cawley EI, Park S, ba het Rot M, Sancton K, Benkelfat C, Matashi SN, Boivin D, Leyton M. Dopamine da haske: tasirin yanayi da jihohi masu saurin motsawa a cikin mata masu saurin yanayi. Taron 33rd na Kwalejin Kanada na Neuropsychopharmacology.2010.
  38. Chase HW, Eickhoff SB, Laird AR, Hogarth L. Tushen tushen motsawar ƙwayar cuta da haɓakawa: ƙaddamar da alama ta hanyar meta-analysis. Ilimin halayyar dan adam. 2011; 70: 785 – 793. [PubMed]
  39. Yarinyar AR, Ehrman RN, Wang Z, Li Y, Sciortino N, Hakun J, Jens W, Suh J, Listerud J, Marquez K, Franklin T, Langleben D, Detre J, O'Brien CP. Tsammani don sha'awar: kunnawar limbic ta hanyar amfani da miyagun ƙwayoyi da bayyanar jima'i. PLOS DAYA. 2008; 3 (1): e1506. [PMC free article] [PubMed]
  40. Yarinyar AR, Hole AV, Ehrman RN, Robbins SJ, McLellan AT, O'Brien CP. Cue reactivity da kuma cue reactivity shisshigi a cikin magani. Cibiyar Nazarin Binciken Miyagun Kwayoyi ta Kasa. 1993; 137: 73 – 95. [PubMed]
  41. Yarinyar AR, McLellan AT, Ehrman R, O'Brien CP. Amsa da aka sanya a ka'idodi a cikin cocaine da kuma dogara da opioid: wani aiki cikin komatawa? A: Ray BA, edita. Abubuwan Ilmantarwa na Ilmantarwa. Fitowa 84. Cibiyar Nazarin Binciken Miyagun Kwayoyi ta Kasa. Ma'aikatar Lafiya ta Amurka da Ayyukan Jama'a; Rockville, MD: 1988. p. 25 – 43.
  42. San E, de Wit H. Amphetamine-fifikon fifiko a cikin mutane. Ilimin halayyar dan adam. 2009; 15: 900 – 904. [PMC free article] [PubMed]
  43. San Yara E, de Wit H. Maganin yanayin mahaifa yana haɓaka psychostimulant da kayan kwantar da hankali na d-amphetamine a cikin mutane. Labarin Batsa. a latsa. [PMC free article] [PubMed]
  44. Ciccocioppo R, Martin-Fardon R, Weiss F. Stimuli wanda aka danganta shi da gogewar cocaine guda daya ya haifar da neman maganin koko na dadewa. Yanayin Neuroscience. 2004; 7: 495 – 496. [PubMed]
  45. Claus ED, Ewing SWF, Filbey FM, Sabbineni A, Hutchison KE. Bayyana kwayoyin halittun neurobiological da ke hade da amfani da giya. Neuropsychopharmacology. 2011; 36: 2086 – 2096. [PMC free article] [PubMed]
  46. Cloutier J, Heatherton TF, Whalen PJ, Kelley WM. Shin mutane masu jan hankali suna da lada? Banbancin Jima'i a jikin abubuwan canza yanayin fuska. Jaridar Cognitive Neuroscience. 2008; 20: 941 – 951. [PMC free article] [PubMed]
  47. Conaglen HM, Evans IM. Kabilun makiyaya da sha'awar jima'i: tsarin gwaji. Bayanan Aiki na Jima'i. 2006; 35: 201 – 216. [PubMed]
  48. Jaka Connell. Amphetamine Psychosis, Maudsley Monograph Babu 5. Chapman da Hall; London: 1958.
  49. Conrod PJ, Pihl RO, Stewart SH, Dongier M. Ingantaccen tsarin da aka rarraba masu shaye-shayen mata bisa ga halaye da dalilai masu haɗarin motsa jiki. Ilimin halin dan Adam na Addictive Behaviors. 2000; 14: 243 – 256. [PubMed]
  50. Cortright JJ, Sampedro GR, Neugebauer NM, Vezina P. Bayyanar da ta gabata zuwa nicotine yana inganta tasirin motsawar motsa jiki na amphetamine ta hanyar abubuwan da ke tattare da nicotine. Neuropsychopharmacology. 2012; 37: 2277 – 2284. [PMC free article] [PubMed]
  51. Cox SML, Benkelfat C, Dagher A, Delaney JS, Durand F, McKenzie SA, Kolivakis T, Casey KF, Leyton M. Striatal dopamine martani ga sarrafa kansa na cocaine a cikin mutane. Ilimin halayyar dan adam. 2009; 65: 846 – 850. [PubMed]
  52. Cox WM, Fadardi JS, Pothos EM. Jarabawar jaraba Stroop: ka'idojin tunani da shawarwari na tsari. Bulletin Ilimin halin dan Adam. 2006; 32: 443 – 476. [PubMed]
  53. Culbertson C, Nicolas S, Zaharovits I, London ED, de la Garza R, II, Brody AL, Newton TF. Methamphetamine nema nema a cikin wani online kama-da-wane gaskiyar yanayin. Magungunan Magungunan Halittu da Halayya. 2010; 96: 454 – 460. [PMC free article] [PubMed]
  54. Dar R, Rosen-Korain N, Shapira O, Gottlieb Y, Frenk H. Babban sha'awar hayaki a cikin masu halartar jirgin sama: alaƙa da ƙarancin shan sigari, tsammanin shan sigari, da kuma ainihin shan sigari. Jaridar Ilimin Jima'i. 2010; 119: 248 – 253. [PubMed]
  55. Dar R, Stronguin F, Marouani R, Krupsky M, Frenk H. Craving don shan sigari a cikin masu shan sigari na gargajiya waɗanda ke kauracewa ranar Asabaci: kwatancen zuwa tushe da tilasta tilasta aiki ranar aiki. Psychopharmacology. 2005; 183: 294 – 299. [PubMed]
  56. Davis C, Curtis C, Levitan RD, Carter JC, Kaplan AS, Kennedy JL. Shaida cewa 'kayan maye' ingantaccen abu ne na ƙurar kiba. Ci. 2011; 57: 711 – 717. [PubMed]
  57. Dawson DA, Harford TC, Grant BF. Tarihin dangi a matsayin annabta game da maye giya. Alcoholism: Clinical da Gwajin Nazari. 1992; 16: 572 – 575. [PubMed]
  58. de Lange FP, van Gaal S, Lamme VAF, Dehaene S. Yadda wayar da kan jama'a ke canza mahimmancin shaida yayin yanke hukunci na ɗan adam. PLOS DAYA. 2011; 9: e1001203. [PMC free article] [PubMed]
  59. Demos KE, Heatherton TF, Kelley WM. Bambancin daidaikun mutane a cikin kwayoyi suna hana mutum zuwa abinci da hotunan jima'i yana tsinkayar samun nauyi da halayyar jima'i. Jaridar Neuroscience. 2012; 32: 5549 – 5552. [PMC free article] [PubMed]
  60. De Ridder D, Vanneste S, Kovacs S, Sunaert S, Dom G. alcoholanƙarar bugun giya na baƙin ciki ta hanyar rTMS na dorsal face ining: wani fMRI da LORETA EEG nazarin. Haruffa da Neuroscience. 2011; 496: 5 – 10. [PubMed]
  61. de Ruiter MB, Veltman DJ, Goudriaan AE, Oosterlaan J, Sjoerds Z, van den Brink W. Rashin jituwa da aƙwalwar frontaƙwalwar gabbai don sakamako da ladabtarwa a cikin matsalar rsan wasan caca da sigari. Neuropsychopharmacology. 2009; 34: 1027 – 1038. [PubMed]
  62. de Wit H. Priming sakamako tare da kwayoyi da sauran masu ƙarfafawa. Gwajin gwaji da na asibiti Psychopharmacology. 1996; 4: 5 – 11.
  63. de Wit H, Phillips TJ. Shin martani na farko game da kwayoyi suna ƙaddara amfani da amfani nan gaba? Nazarin Labarin ƙwayoyin cuta da kuma nazarin halittu. 2012; 36: 1565 – 1576. [PMC free article] [PubMed]
  64. de Wit H, Stewart J. Sake dawo da martabar hodar Iblis a cikin bera. Psychopharmacology. 1981; 75: 134 – 143. [PubMed]
  65. Di Ciano P, Blaha CD, Phillips AG. Sauye-sauye da ake samu a halin hada doksamine hada-hada a cikin ƙwayoyin tsokoki ta hanyar ƙarfafawa da aka haɗa tare da gudanar da kai ko gudanarwa na d-amphetamine. Jaridar Turai ta Nazarin ilimin halittar kwakwalwa. 1998; 10: 1121 – 1127. [PubMed]
  66. Dodds CM, O'Neil B, Beaver J, Makwana A, Bani M, Merlo-Pich E, Flecther PC, Koch A, Bullmore ET, Nathan PJ. Tasirin dopamine D3 mai karɓar GSK598809 mai karɓar raunin kwakwalwa game da martanin kwakwalwa don biyan hotunan abinci a cikin kiba da masu kiba masu yawa. Ci. 2012; 59: 27 – 33. [PubMed]
  67. Doudet DJ, Holden JE. Nazarin Raclopride na sakin dopamine: dogaro kan amincin presynaptik. Ilimin halayyar dan adam. 2003; 54: 193 – 199. [PubMed]
  68. Droungas A, Ehrman RN, Childress AR, O'Brien CP. Sakamakon shan taba sigari da kuma yawan shan sigari akan halayyar siga da kuma shan sigari. Beabi'a masu jaraba. 1995; 20: 657 – 673. [PubMed]
  69. Dutra L, Stathopolous G, Basden SL, Leyro TM, Powers MB, Otto MWA. Metaarin nazarin-meta na nazarin abubuwan da ke tattare da cutar psychosocial don rikicewar amfani da abubuwa. American Journal of Psychiatry. 2008; 165: 179 – 187. [PubMed]
  70. Duvauchelle CL, Ikegami A, Castaneda E. Yanayin zama yana ƙaruwa a cikin halayyar haɓaka da matakan dopamine na ƙwayoyin cuta wanda aka samar da ƙwayar koko. Harkokin Nunin ƙwaƙwalwa. 2000; 114: 1156 – 1166. [PubMed]
  71. Eikelboom R, Stewart J. Bayyanar da martani na magunguna. Nazarin Ilimin Jima'i. 1982; 89: 507 – 528. [PubMed]
  72. Ellinwood EH. Amphetamine psychosis: I. Bayanin mutane da tsari. Jaridar Cututtukan Cuta da Cutar Hauka. 1967; 144: 273 – 283.
  73. Enoch MA, Hodgkinson CA, Yuan Q, Shen PH, Goldman D, Roy A. Tasirin GABRA2, rauni na yara, da ma'amalarsu game da barasa, tabar heroin, da kuma maganin cocaine. Ilimin halayyar dan adam. 2010; 67: 20 – 27. [PMC free article] [PubMed]
  74. Epstein DH, Willner-Reid J, Vahabzadeh M, Mezghanni M, Lin JL, Preston KL. Rahoton bayanan lantarki na lokaci-lokaci na bayyanar cue da yanayi a cikin sa'o'i kafin cocaine da tabar heroin sha'awar da amfani. Sanarwa na Janar Psychiatry. 2009; 66: 88 – 94. [PMC free article] [PubMed]
  75. Ernst M, Fudge JL. Wani haɓakar ƙirar neurobiological na halayyar motsa jiki: ilmin jikin mutum, haɗi da jijiyoyin gwiwa na jijiyar triadic. Nazarin Labarin ƙwayoyin cuta da kuma nazarin halittu. 2009; 33: 367 – 382. [PMC free article] [PubMed]
  76. Ernst M, Nelson EE, Jazbec S, McClure EB, Monk CS, Leibenluft E, Blair J, Pine DS. Amygdala da kwayar halitta suna mayar da martani cikin karɓar karɓar fa'ida ga manya da matasa. NeuroImage. 2005; 25 (4): 1279 – 1291. [PubMed]
  77. Evans AH, Pavese N, Lawrence AD, Tai YF, Appel S, Doder M, Brooks DJ, Lees AJ, Piccini P. Rashin amfani da miyagun ƙwayoyi yana da alaƙa da watsawar senswalar ƙwayar cuta dopamine. Labarun Lantarki 2006; 59: 852 – 858. [PubMed]
  78. Fadardi JS, Cox WM. Komawa ga tsarin: rage shan barasa ta hanyar shawo kan giya mai kyau. Magunguna da Shan Giya. 2009; 101: 137 – 145. [PubMed]
  79. Fatseas M, Denis C, Massida Z, Verger M, Franques-Rénéric P, Auriacombe M. Cue-inacced reactivity, cortisol amsa da sakamako na amfani da kayan maye a cikin mutanen da ke kula da tabar heroin. Ilimin halayyar dan adam. 2011; 70: 720 – 727. [PubMed]
  80. Ferguson CS, Tyndale RF. Enzymes na Cytochrome P450 a cikin kwakwalwa: fitowar shaida game da mahimmancin kwayoyin halitta. Trends a ilimin kimiyyar magunguna. 2011; 32: 708 – 714. [PMC free article] [PubMed]
  81. Field M, Munafò MR, Franken IHA. Binciken meta na nazari game da alaƙar da ke tsakanin banbancin ra'ayi da sha'awar cutarwa. Bulletin Ilimin halin dan Adam. 2009; 135: 589 – 607. [PMC free article] [PubMed]
  82. Filbey FM, Claus E, Audette AR, Niculescu M, Banich MT, Du YP, Hutchison KE. Bayyanar ga dandano na giya na haifar da kunnawa na mccocuicolimbic neurocircuitry. Neuropsychopharmacology. 2008; 33: 1391 – 1401. [PMC free article] [PubMed]
  83. CD din Fiorillo, Tobler PN, Schultz W. Tsarin kirkirar sakamako mai yiwuwa kuma rashin tabbas da kwayoyin dopamine. Kimiyya. 2003; 299: 1898-1902. [PubMed]
  84. Fischman MW. Dangantaka tsakanin cututtukan da aka bayar da rahoton kansu da tasirin ƙarfafa su: karatu tare da kwayoyi masu ƙarfafawa. NIDA Bincike Monograph. 1989; 92: 1211 – 1230. [PubMed]
  85. Flagel SB, Clark JJ, Robinson TE, Mayo L, Czuj A, Willuhn I, Akers CA, Clinton SM, Phillips PEM, Akil H. Matsayi mai kyau don dopamine a cikin karatun sakamako. Yanayi. 2011; 469: 53 – 57. [PMC free article] [PubMed]
  86. Foltin RW, Haney M. Sakamakon yanayi na haɓaka muhalli ya haɗu tare da shan shunin a cikin mutane. Psychopharmacology. 2000; 149: 24 – 33. [PubMed]
  87. Fotros A, Casey KF, Larcher K, Verhaeghe JAJ, Cox SM, Gravel P, Reader AJ, Dagher A, Benkelfat C, Leyton M. Cue-induced dopamine sakin a cikin yankuna masu rikice-rikice da rikice-rikice a cikin masu amfani da maganin koko. ƙuduri PET [18F] binciken fallypride. 10th International Catecholamine Symposium.2012.
  88. Franken IH, Hendriks VM, Stam CJ, van den Brink W. Matsayi don dopamine a cikin aiwatar da alamun cuwa-cuwa a cikin marasa lafiya na dogara da tabar heroin. Turai Neuropsychopharmacology. 2004; 14: 503 – 508. [PubMed]
  89. Frascella J, Potenza MN, Brown LL, Kayan yarinyar AR. Rashin raunin kwakwalwa yana buɗe hanya don jarabawar rashin sani: jaraba sassaka a wani sabon haɗin gwiwa? Labarun Kwalejin Kimiyya ta New York. 2010; 1187: 294 – 315. [PMC free article] [PubMed]
  90. Galvan A, Hare TA, Parra CE, Penn J, Voss H, Glover G, Casey BJ. Farkon ci gaban abubuwa na lafazi mai ma'ana ga orbitofrontal cortex na iya zama halayyar haɗari ga matasa. Jaridar Neuroscience. 2006; 26: 6885 – 6892. [PubMed]
  91. Garavan H, Pankiewicz J, Bloom A, Cho JK, Sperry L, Ross TJ, Salmeron BJ, Risinger R, Kelley D, Stein EA. Shaƙar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwa: ƙayyadaddun ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwa don masu amfani da miyagun ƙwayoyi da ƙwarin maganin. American Journal of Psychiatry. 2000; 157: 1789 – 1798. [PubMed]
  92. Geier CF, Terwilliger R, Teslovich T, Velanova K, Luna B. Tasiri a cikin aikin lada da tasirin sa akan sarrafa inhibitory a cikin samartaka. Cerebral Cortex. 2010; 20: 1613 – 1629. [PMC free article] [PubMed]
  93. Gearhardt AN, Farin MA, Potenza MN. Rashin cin abinci da kuma matsalar abinci. Reviews Abuse na Magunguna Na Zamani. 2011; 4: 201 – 207. [PMC free article] [PubMed]
  94. George MS, Anton RF, Bloomer C, Teneback C, Drobes DJ, Lorberbaum JP, Nahas Z, Vincent DJ. Kunna cortex na prefrontal cortex da thalamus na gaba a cikin batutuwa na giya akan haɗuwa da takamaiman abubuwan da ke nuna barasa. Sanarwa na Janar Psychiatry. 2001; 58: 345 – 352. [PubMed]
  95. Gilman JM, Ramchandani VA, Crouss T, Hommer DW. Abubuwan da aka gabatar da su na wucin gadi da ƙananan ƙwayoyin cuta zuwa cikin barasa na yara a cikin samari tare da haske da nauyi tsarin sha. Neuropsychopharmacology. 2012; 37: 467 – 477. [PMC free article] [PubMed]
  96. Goldstein RZ, Craig AD, Bechara A, Garavan H, Yarinyar AR, Paulus MP, Volkow ND. The neurocircuitry na gurbata haske a cikin jaraba na miyagun ƙwayoyi. Trends a cikin Sanin Kimiyya. 2009; 13: 372 – 380. [PMC free article] [PubMed]
  97. Grabowski J, Rhoades H, Silverman P, Schmitz J, Stotts A, Creson D, Rahn B. Risperidone don maganin dokin maye: bazuwar, gwajin makanta biyu. Jaridar Clinical Psychopharmacology. 2000; 20: 305 – 310. [PubMed]
  98. Griffith JD, Cavanaugh J, Held J, Oates JA. Dextroamphetamine: kimantawa da kaddarorin psychotomimetc a cikin mutum. Sanarwa na Janar Psychiatry. 1972; 26: 97 – 100. [PubMed]
  99. Grimm JW, Hope BT, Mai hikima RA, Shaham Y. Haɓaka ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwa bayan cirewa. Yanayi. 2001; 412: 141 – 142. [PMC free article] [PubMed]
  100. Grüsser SM, Wrase J, Klein S, Hermann D, Smolka MN, Ruf M, Weber-Fahr W, Flor H, Mann K, Braus DF, Heinz A. Cue-induced activates of the striatum and medial prefrontal cortex yana da alaƙa da mai zuwa koma baya cikin masu maye giya. Psychopharmacology. 2004; 175: 296 – 302. [PubMed]
  101. Guillory AM, Suto N, Kuna ZB, Vezina P. Sakamakon hanawar hana motsa jiki a kan ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwa a cikin ƙwayoyin ƙwayoyin cuta. Society for Neuroscience. 2006; 32: 483 – 493. Abubuwan kunya.
  102. Hakyemez HS, Dagher A, Smith SD, Zald DH. Striatal dopamine yadawa yayin aikin bada lamuni mai gudana. NeuroImage. 2008; 15: 2058 – 2065. [PubMed]
  103. Hamamura T, Akiyama K, Akimoto K, Kashihara K, Okumura K, Ujike H, Otsuki S. Co-Administrator ko dai zaɓin D1 ko D2 dopamine mai adawa tare da methamphetamine yana hana methamphetamine-jawo halayen hankali da canjin ƙwaƙwalwar ƙwaƙwalwa, binciken da vivo intracerebral dialysis. Binciken Kwakwalwa. 1991; 546: 40 – 46. [PubMed]
  104. Hamann S, Herman RA, Nolan CL, Wallen K. Maza da mata sun bambanta a amsa amygdala ga abubuwan jima'i na jima'i. Yanayin Neuroscience. 2004; 7: 411-416. [PubMed]
  105. Herman CP. Abubuwan waje da na ciki kamar ƙaddarar halayen shan sigari na haske da masu shan sigari. Jaridar mutum da ilimin halayyar dan adam. 1974; 30: 664 – 672. [PubMed]
  106. Hernandez L, Wager T, Jonides J. Gabatarwa zuwa aikin neuroimaging mai aiki. A: Cabeza R, Kingstone A, masu gyara. Littafin Jagora na aikin Nesa Tsarin Kwarewa. Fasali 1 MIT Press; Cambridge (MA): 2001.
  107. Hitsman B, MacKillop J, Lingford-Hughes A, Williams TM, Ahmad F, Adams S, Nutt DJ, Munafó MR. Sakamakon mummunar cutar mahaifa / taɓarɓarewar ƙwayar cuta ta mahaɗa akan aikin zaɓi na abubuwan da suka shafi shan sigari da kuma ƙimar kuɗaɗen taba sigari. Psychopharmacology. 2008; 196: 611 – 621. [PubMed]
  108. Hogarth L, Dickinson A, Wright A, Kouvaraki M, Duka T. Matsayin begen shaye-shayen ƙwaƙwalwar ƙwaƙwalwar ƙwayar ɗan adam. Jaridar Ilimin Jima'i. 2007; 33: 484 – 496. [PubMed]
  109. Hogarth L, Dickinson A, Duka T. Tushen hadin gwiwar magungunan mutane masu amfani da kwayoyi. Psychopharmacology. 2010; 208: 337 – 351. [PubMed]
  110. Hogarth L, Dickinson A, Janowski A, Nikitina A, Duka T. Matsayin banbancin ra'ayi wajen daidaita dabi'un mutane na neman kwayoyi. Psychopharmacology. 2008; 201: 29 – 41. [PubMed]
  111. Hommer RE, Seo D, Lacadie CM, Chaplin TM, Mayes LC, Sinha R, Potenza MN. Neural correlates of stress da kuma fi so-abinci cue wahayi a cikin matasa: wani aiki ikon magana da maganganu maganadisu ikon daukar hoto. Zane na Humanan Adam. a latsa. [PMC free article] [PubMed]
  112. Buga CC. Halaye da kuma illolin da suka danganci ci gaban haƙuri. A cikin: Mulé SJ, Brill H, masu gyara. Abubuwan da ke tattare da Kemikal da Halittu game da Dogara. Latsa CRC; Cleveland: 1972. p. 307 – 358.
  113. Hutcheson DM, Everitt BJ, Robbins TW, Dickinson A. Matsayin karbowa a cikin jarabar tabar heroin: inganta sakamako ko inganta haɓaka? Yanayin Neuroscience. 2001; 4: 943 – 947. [PubMed]
  114. Hyatt CJ, Assaf M, Muska CE, Rosen RI, Thomas AD, Johnson MR, Hylton JL, Andrews MM, Reynolds BA, Krystal JH, Potenza MN, Pearlson GD. Bambance-bambancen aiki na dorsal mai yuwuwa a tsakanin tsoffin kokenan dogaro da na yanzu yayin wasan gasa. PLOS DAYA. 2012; 7: e34917. [PMC free article] [PubMed]
  115. Hyman SM, Garcia M, Sinha R. specificwararrun ƙungiyoyi tsakanin nau'ikan zalunci na yara da farawa, haɓaka da kuma tsananin amfani da abu a cikin manya-mutanen da ke da dokin. Jaridar nan ta Amurka ta Ruwa da Almubazzaranci. 2006; 32: 655 – 664. [PMC free article] [PubMed]
  116. Ihssen N, Cox WM, Wiggett A, Fadardi JS, Linden DEJ. Bambanta mai nauyi daga masu shaye-shaye ta hanyar mayar da martani game da alamun barasa da sauran abubuwan karfafawa. Cerebral Cortex. 2011; 21: 1408 – 1415. [PubMed]
  117. Ito R, Dalley JW, Howes SR, Robbins TW, Everitt BJ. Rashin daidaituwa a cikin yanayin saki na dopamine a cikin ƙwayar ƙwaƙwalwar ƙwayar ƙwaƙwalwa yana ɓoye ƙoshin ƙira da harsashi don amsa kiran cocaine da yayin halayen neman cocaine a cikin beraye. Jaridar Neuroscience. 2000; 20: 7489 – 7495. [PubMed]
  118. Jansen A. Tsarin ilmantarwa na cin abinci kamar: sake kunnawa da nuna yanayin nuna alama. Binciken Halayyar Nazari da Lafiya. 1998; 36: 257 – 272. [PubMed]
  119. Jia Z, Worhunsky PD, Carroll KM, Rounsaville BJ, Stevens MC, Pearlson GD, Potenza MN. Nazarin farko game da martani na ƙarancin kuɗi don ƙwarin gwiwar kuɗi kamar abin da ya shafi sakamakon magani a cikin dogaro na cocaine. Ilimin halayyar dan adam. 2011; 70: 553 – 560. [PMC free article] [PubMed]
  120. Johanson CE, Uhlenhuth EH. Abubuwan da ake so game da miyagun ƙwayoyi da yanayi a cikin mutane: sake maimaita kima na d-amphetamine. Magungunan Magungunan Halittu da Halayya. 1981; 14: 159 – 163. [PubMed]
  121. Joutsa J, Johansson J, Niemela S, Ollikainen A, Hirvonen MH, Piepponen P, Arponen E, Alho H, Voon V, Rinne JO, Hietala J, Kaasinen V. Mesolimbic dopamine saki yana da alaƙa da tsananin ciwo a cikin caca. NeuroImage. 2012; 60: 1992 – 1999. [PubMed]
  122. Juliano LM, Brandon TH. Komawa ga gano shan sigari da abubuwan da ke cikin muhalli: shaida tare da kwazo da lokacin dauki Gwajin gwaji da na asibiti Psychopharmacology. 1998; 6: 45 – 53. [PubMed]
  123. Kampman KM, Pettinati H, Lynch KG, Sparkman T, O'Brien CP. Gwajin matukin jirgi na olanzapine don magance dogaro da maganin koko. Magunguna da Shan Giya. 2003; 70: 265 – 273. [PubMed]
  124. Kareken DA, Bragulat V, Dzemidzic M, Cox C, Talavage T, Davidson D, O'Connor SJ. Tarihin dangi game da giya ya ba da amsa ga fuskar gaban masu shan giya da giya a cikin masu saurin haɗari. NeuroImage. 2010; 50: 267 – 276. [PMC free article] [PubMed]
  125. Kareken DA, Claus ED, Sabri M, Dzemidzic M, Kosobud AEK, Radnovich AJ, Hector D, Ramchandani VA, O'Connor SJ, Lowe M, Li TK. Abubuwan da ke da alaƙa da barasa suna kunna ƙwayoyin ƙwaƙwalwar mahaifa da yankin ventral ɓangara a cikin masu shan haɗari: Sakamakon farko. Alcoholism: Clinical da Gwajin Nazari. 2004; 28: 550 – 557. [PubMed]
  126. Kelley AE, Berridge KC. The neuroscience na halitta lada: dacewar ga jaraba kwayoyi. Jaridar Neuroscience. 2002; 22: 3306 – 3311. [PubMed]
  127. Kelly TH, Foltin RW, Fischman MW. Sakamakon sake bayyana amphetamine akan matakan da yawa na halayen mutane. Magungunan Magungunan Halittu da Halayya. 1991; 38: 417 – 426. [PubMed]
  128. Kendler KS, Chen X, Dick D, Maes H, Gillepsie N, Neale MC, Riley B. Ci gaban da aka samu kwanan nan a cikin kwayoyin halittar jini da kwayoyin halittar kwayoyin cuta na rikicewar amfani da abubuwa. Yanayin Neuroscience. 2012; 15: 181 – 189. [PMC free article] [PubMed]
  129. Kendler KS, Davis CG, Kessler RC. Taron dangi na cututtukan ƙwaƙwalwa na yau da kullun da rikice-rikice masu amfani da amfani a cikin Binciken orarfin Nationalasa: nazarin tarihin iyali. British Journal of Psychiatry. 1997; 170: 541 – 548. [PubMed]
  130. Kendler KS, Prescott CA, Myers J, Neale MC. Tsarin kwayoyin halitta da abubuwan da ke haifar da barazanar muhalli don cututtukan kwakwalwa na yau da kullun da amfani da cuta a cikin maza da mata. Sanarwa na Janar Psychiatry. 2003; 60: 929 – 937. [PubMed]
  131. Kim BK, Zauberman G. Shin Asirin Victoria zai canza nan gaba? Labarin tsinkaye lokaci na abubuwan da suka shafi jima'i a cikin rashin haƙuri. Jaridar Nazarin Ilimin Jima'i: Janar. a latsa. [PubMed]
  132. Kim JH, Austin JD, Tanabe L, Creekmore E, Vezina P. ofarfafa rukuni na II mGlu masu karɓar magunguna sun toshe ingantaccen magungunan shan induwar ta hanyar haɗuwa da amphetamine na baya. Jaridar Turai ta Nazarin ilimin halittar kwakwalwa. 2005; 21: 295 – 300. [PubMed]
  133. King A, McNamara P, Angstadt M, Phan KL. Kwatankwacin wurare masu maye na shan giya wanda ke sa maye a cikin masu shan sigari mara nauyi. Neuropsychopharmacology. 2010; 35: 692 – 701. [PMC free article] [PubMed]
  134. Koepp MJ, Gunn RN, Lawrence AD, Cunningham VJ, Dagher A, Jones T, Brooks DJ, Bench CJ, Grasby PM. Shaida don kwancewar dopamine yayin wasan bidiyo. Yanayi. 1998; 393: 266 – 268. [PubMed]
  135. Knutson B, Cooper JC. Aikin aiki na Magnetic resonance na hasashen sakamako. Ra'ayin yanzu a cikin ilimin halittar jini. 2005; 18: 411 – 417. [PubMed]
  136. Koob GF, Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Kimiyya. 1997; 278: 52-58. [PubMed]
  137. Krueger RF. Tsarin magungunan tunani na yau da kullum. Archives na General Psychiatry. 1999; 56: 921-926. [PubMed]
  138. Kühn S, Romanowski A, Schilling R, Mörsen C, Seiferth N, Banaschewski T, Barbot A, Barker GJ, Büchel C, Conrod PJ, Dalley JW, Flor H, Garavan H, Ittermann B, Mann K, Martinot JL, Paus T , Rietschel M, Smolka MN, Ströhle A, Walaszek B, Schumann G, Heinz A, Gallinat J. The IMAGEN Consortium. Dalili na tushen wasan bidiyo. Fassarar ƙwaƙwalwa. 2011; 15: e53. [PMC free article] [PubMed]
  139. Lamb RJ, Preston KL, Schindler C, Meisch RA, Davis F, Katz JL, Henningfield JE, Goldberg SR. Thearfafawa da kuma tasirin ciwan ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta a cikin addicts: ƙwarewar-binciken amsa. Journal of Pharmacology da gwajin ilimin kwalliya. 1991; 259: 1165 – 1173. [PubMed]
  140. Laruelle M. Tasirin maganin hana daukar ciki na synaptik tare da a cikin dabarun gasar cin nasara: bita mai mahimmanci. Journal of Harkokin Jinin Cerebral da Tsarin Magani. 2000; 20: 423 – 452. [PubMed]
  141. Leeman RF, Potenza MN. Kamanceceniya da bambance-bambance tsakanin caca da cutar amfani da abubuwa: mai da hankali ga sha'awar jiki da kuma tursasawa rayuwa. Psychopharmacology. 2012; 219: 466 – 490. [PMC free article] [PubMed]
  142. Leyton M. Sanyaya da tunanin mai martaba ga abubuwan motsa jiki a cikin mutane. Ci gaba a cikin Neuro-psychopharmacology da ilimin halayyar halittu. 2007; 31: 1601 – 1613. [PubMed]
  143. Leyton M, ba na Rot M, Booij L, Baker GB, Young SN, Benkelfat C. Hanyoyin haɓakawa na d-amphetamine da haɓaka mai motsawa: sakamakon ƙarancin ƙarancin kwayar dopamine. Jaridar Lafiya da Lafiya da Lafiya. 2007; 32: 129-136. [PMC free article] [PubMed]
  144. Leyton M, Boileau I, Benkelfat C, Diksic M, Baker GB, Dagher A. Amphetamine-induced yana ƙaruwa da karin ƙwayar cuta, ƙwaƙwalwar ƙwayoyi, da kuma sabon labari suna neman: nazarin PET / [11C] na raclopride a cikin maza masu lafiya. Neuropsychopharmacology. 2002; 27: 1027 – 1035. [PubMed]
  145. Leyton M, Casey KF, Delaney JS, Kolivakis T, Benkelfa tC. Cocaine so, euphoria, da gudanar da kai: bincike na farko game da tasirin maganin catecholamine. Harkokin Nunin ƙwaƙwalwa. 2005; 119: 1619 – 1627. [PubMed]
  146. Leyton M, Vezina P. A kan adon kuɗaɗe: ɗimbin rikice-rikice a cikin jaraba. Ilimin halayyar dan adam. 2012; 72: e21 – e22. [PMC free article] [PubMed]
  147. Li Q, Wang Y, Zhang Y, Li W, Yang W, Zhu J, Wu N, Chang H, Zheng Y, Qin W, Zhao L, Yuan K, Liu J, Wang W, Tian J. Craving sun daidaita da martanin mesolimbic zuwa lambobin da ke da alaƙa da tabar heroin a kaurace wa ɗan gajeren lokaci: binciken FMRI mai alaƙa da taron. Binciken Kwakwalwa. 2012; 1469: 63 – 72. [PubMed]
  148. Lidstone SC, Schulzer M, Dinelle K, Mak E, Sossi V, Ruth TJ, de la Fuente-Fernández R, Phillips AG, Stoessl AJ. Sakamakon fata game da sakin magunguna na kwayar cutar sankara a cikin Cutar Parkinson. Sanarwa na Janar Psychiatry. 2010; 67: 857 – 865. [PubMed]
  149. Lingford-Hughes AR, Daglish MRC, Stevenson BJ, Feeney A, Pandit SA, Wilson SJ, Myles J, Grasby PM, Nutt DJ. Bayyanar kyautar cue cue a cikin barasa ta amfani da PET 15O-H2-O misali: sakamako daga binciken matukan jirgi. Labarin Batsa. 2006; 11: 107 – 115. [PubMed]
  150. Linnet J, Peterson E, Doudet DJ, Gjedde A, Moller A. Dopamine saki a cikin ventral striatum na 'yan caca da ke kashe kuɗi. Scandinavica Acta Psychiatrica. 2010; 122: 326 – 333. [PubMed]
  151. Linnet J, Peterson E, Gjedde A, Doudet DJ. Associationungiyar takurawa tsakanin dopaminergic neurotransmission da Iowa Caca Task wasan kwaikwayon a cikin caca pathologies da lafiya iko. Scandinavian Journal of Psychology. 2011; 52: 28 – 34. [PubMed]
  152. Little KY, Krolewski DM, Zhang L, Cassin BJ. Asarar vesicular monoamine jigilar furotin (VMAT2) a cikin masu amfani da maganin cocaine. American Journal of Psychiatry. 2003; 160: 47 – 55. [PubMed]
  153. Little KY, Ramssen E, Welchko R, Volberg V, Roland CJ, Cassin B. Rage lambobin ƙwayoyin dopamine na kwakwalwa a cikin masu amfani da ƙwayar mutane. Binciken Hauka. 2009; 168: 173 – 180. [PubMed]
  154. Little M, Euser AS, Munafò MR, Franken IHA. Abubuwan da aka fahimta na electrophysiological na nuna rashin fahimta aiki na abubuwan da ke da alaƙa da samfuri: ƙirar-meta. Nazarin Labarin ƙwayoyin cuta da kuma nazarin halittu. 2012; 36: 1803 – 1816. [PubMed]
  155. Lodge DJ, Grace AA. Amphetamine kunnawa na aikin hippocampal na mesolimbic dopamine neurons: hanyar tsarin kula da halayyar mutum. Jaridar Neuroscience. 2008; 28: 7876 – 7882. [PMC free article] [PubMed]
  156. Lou M, Wang E, Shen Y, Wang J. Cue-neman sha'awar jarabar heroin a lokuta daban-daban na kamewa: nazarin matukin jirgi na fMRI. Amfani da Abubuwa & Amfani. 2012; 47: 631-639. [PMC free article] [PubMed]
  157. Loweth JA, Li D, Cortright JJ, Wilke G, Jeyifous O, Neve RL, Bayer KU, Vezina P. Juyin juya hali na inganta amphetamine ta hanyar jigilar CaMKII mai jinkiri. Jaridar Neuroscience. 2013; 33: 1411 – 1416. [PMC free article] [PubMed]
  158. Mahler SV, de Wit H. Cue-reactors: bambance-bambancen mutum cikin sha'awar sha'awar abinci bayan cin abinci ko kuma shan sigari. Shirye DAYA. 2010; 5: e15475. [PMC free article] [PubMed]
  159. Mariani JJ, Pavlicova M, Bisaga A, Nunes EV, Brooks DJ, Levin FR. Aukewar-cakuda gishirin amphetamine da topiramate don dokin maye: gwaji mai sarrafa kansa. Ilimin halayyar dan adam. 2012; 72: 950 – 956. [PMC free article] [PubMed]
  160. Martinez D, Kafinta, KM, Liu F, Slifstein M, Broft A, Friedman AC, Kumar D, van Heertum R, Kleber HD, Nunes E. Hoton watsa dopamine a cikin dogaro na koko: hanyar haɗi tsakanin neurochemistry da mayar da martani ga magani. American Journal of Psychiatry. 2011; 168: 634 – 641. [PMC free article] [PubMed]
  161. Martinez D, Gil R, Slifstein M, Hwang DR, Huang Y, Perez A, Kegeles L, Talbot P, Evans S, Krystal J, Laruelle M, Abi-Dargham A. Abin dogaro na barasa yana da alaƙa da watsawar dopamine mai ban tsoro a cikin wutar lantarki . Ilimin halayyar dan adam. 2005; 58: 779 – 786. [PubMed]
  162. Martinez D, Greene K, Broft A, Kumar D, Liu F, Narendran R, Slifstein M, Van Heertum R, Kleber HD. Lowerarancin dopamine na endogenous a cikin marasa lafiya tare da dogaro da ƙwaƙwalwar ƙwaƙwalwa: binciken daga PET hoton mai karɓar D2 / D3 masu biyowa bayan ƙarancin dopamine. American Journal of Psychiatry. 2009; 166: 1170 – 1177. [PMC free article] [PubMed]
  163. Martinez D, Narendran R, Foltin RW, Slifstein M, Hwang DR, Brof tA, et al. Releaseaddamarwa da ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwa: alama ce ta ɓoye cikin dogaro da koko don ƙaddamar da maganin kansa. American Journal of Psychiatry. 2007; 164: 622 – 629. [PubMed]
  164. Martinez D, Saccone PA, Liu F, Slifstein M, Orlowska D, Grassetti A, Cook S, Broft S, van Heertum R, Comer SD. Ficarke a cikin masu karɓa na D2 masu karɓa da dopamine na Dopamine a cikin dogaro na tabar heroin: gama gari da bambance-bambance tare da sauran nau'in jaraba. Ilimin halayyar dan adam. 2012; 71: 192 – 198. [PMC free article] [PubMed]
  165. Martin-Soelch C, Szczepanik J, Nugen A, Barhaghi K, Rallis D, Herscovitch P, Carson RE, Drevets WC. Lateralization da bambance-bambance na jinsi a cikin dopaminergic amsa ga lada wanda ba a iya faɗi ba a cikin hanyar ventral striatum. Jaridar Turai ta Nazarin ilimin halittar kwakwalwa. 2011; 33: 1706 – 1715. [PMC free article] [PubMed]
  166. Mendrek A, Blaha CD, Phillips AG. Bayyanar berayen zuwa amphetamine yana daukar nauyin kansa na wannan magani a ƙarƙashin jadawalin rabo na ci gaba. Psychopharmacology. 1998; 135: 416 – 422. [PubMed]
  167. Mer Guud ELC, Kariminia A, Binswanger IA, Hobbs MS, Farrell M, Marsden J, Hutchison SJ, Bird SM. Meta-bincike game da mutuwar masu alaƙa da miyagun ƙwayoyi jim kaɗan bayan an sake su daga kurkuku. Addua. 2010; 105: 1545 – 1554. [PMC free article] [PubMed]
  168. Merikangas KR, Stolar M, Stevens DE, Goulet J, Preisig MA, Fenton B, Zhang H, O'Malley SS, Rounsaville BJ. Iliaukar watsa labarai na rikicewar amfani da abubuwa. Sanarwa na Janar Psychiatry. 1998; 55: 973 – 979. [PubMed]
  169. Miedl SF, Peters J, Büchel C. An canza alamomin ladan nemo a cikin yan caca da aka saukar ta hanyar jinkiri da kuma ragin yiwuwar ragi. Sanarwa na Janar Psychiatry. 2012; 69: 177 – 186. [PubMed]
  170. Mucha RF, Pauli P, Angrilli A. responididdigar yanayin da aka amsa ta hanyar samfuran gwaji da aka samar don shan sigari. Jaridar Kanada ta Kimiyya da Kimiyya. 1998; 76: 259 – 268. [PubMed]
  171. Mugnaini M, Iavarone L, Cavallini P, Griffante C, Oliosi B, Savoia C, Beaver J, Rabiner EA, Micheli F, Heiderbreder C, Andorn AC, Pich EM, Bani M. GSK598809, mazaunin masu kwakwalwa na dopamine D3 masu karɓar karɓuwa da kuma sha'awar miyagun ƙwayoyi : nazarin fassara. Society for Neuroscience. 2012; 38 Abastracts. [PMC free article] [PubMed]
  172. Munafó MR, Mannie ZN, Cowen PJ, Harmer CJ, McTavish SB. Sakamakon mummunar cutar zazzabin cizon sauro a kan masu ɗabi'ar son zuciya da kuma aiki na abubuwan da suka shafi shan sigari a cikin masu shan sigari. Jaridar Psychopharmacology. 2007; 21: 805 – 814. [PubMed]
  173. Myrick H, Anton RF, Li X, Henderson S, Drobes D, Voronin K, George MS. Harkokin kwakwalwa dabam dabam a cikin masu shayarwa da masu shayarwa ga shaye-giye: dangantaka da sha'awar. Neuropsychopharmacology. 2004; 29: 393-402. [PubMed]
  174. Narendran R, Martinez D. Cutar maganin maganin cocaine da mahimmanci na watsa labaran kwayar cutar: nazari mai mahimmanci game da wallafe-wallafe na wallafe-wallafe da kuma na asibiti. Synapse. 2008; 62: 851-869. [PubMed]
  175. Nutt DJ. Rage Harkokin Rashin Lafiya da Magunguna Lafiya. UIT Cambridge Ltd .; Cambridge, Ingila: 2012. Magunguna Ba tare da Jirgin Sama ba.
  176. Oberlin BG, Dzemidzic M, Bragulat V, Lehigh CA, Talavage T, O'Connor SJ, Kareken DA. Limbic martani ga ladan ma'ana daidai tare da antisecial hali hali da yawa a cikin manyan masu shan giya. NeuroImage. 2012; 60: 644 – 652. [PMC free article] [PubMed]
  177. O'Brien CP, Yarinyar AR, Ehrman R, Robbins SJ. Abubuwan da ke haifar da yanayin yanayin shaye-shayen miyagun ƙwayoyi: shin zasu iya bayyana tilastawa? Jaridar Psychopharmacology. 1998; 12: 15 – 22. [PubMed]
  178. O'Brien CP, Childress AR, McLellan AT, Ehrman R. Haɓaka tsarin sikelin cicicic tare da daidaitaccen magani a dawo da marasa lafiyar da ke dogara da magunguna. Beabi'a masu jaraba. 1990; 15: 355 – 365. [PubMed]
  179. O'Daly OG, Joyce D, Stephan KE, Murray RM, Shergill SS. Binciken fMRI na samfurin amphetamine na schizophrenia a cikin masu sa kai na maza masu lafiya. Sanarwa na Janar Psychiatry. 2011; 68: 545 – 554. [PubMed]
  180. O'Doherty J, Dayan P, Schultz J, Deichmann R, Friston K, Dolan RJ. Matsayin da za'a iya raba shi na bangarorin ventral da na dorsal a cikin yanayin kayan aiki. Kimiyya. 2004; 304: 452 – 454. [PubMed]
  181. O'Sullivan SS, Wu K, Politis M, Lawrence AD, Evans AH, Bose SK, Djamshidan A, Lees AJ, Piccini P. Cire-dopamine mai tayar da hankali a cikin cututtukan cututtukan cututtukan da ke haifar da cutar. Kwakwalwa 2011; 134: 969 – 978. [PubMed]
  182. Panlilio LV, Yasar S, Nemeth-Coslett R, Katz JL, Henningfield JE, Solinas M, Heishman SJ, Schindler CW, Goldberg SR. Halin da ake amfani da hodar Iblis a cikin mutum da sarrafawa ta hanyar ƙaddamar da kwayoyi a cikin dakin gwaje-gwaje. Neuropsychopharmacology. 2005; 30: 433 – 443. [PubMed]
  183. Paulson PE, Camp DM, Robinson TE. Lokaci na rikicewar hali na ɗabi'a da dagewa game da halin ɗabi'a dangane da haɗarin ƙwaƙwalwar ƙwaƙwalwar yanki a yayin cire amphetamine a cikin bera. Psychopharmacology. 1991; 103: 480 – 492. [PMC free article] [PubMed]
  184. Payer D, Boileau I, Lobo D, Chugani B, Behzadi A, Wilson A, Kish S, Houle S, Zack M. Binciken aikin dopamine tare da raclopride [11C] da [11C] - (+) - PHNO PET. Ofungiyar ilimin halayyar halitta. 2012; 434 Abastracts.
  185. Perkins KA. Dole ne al'adu su kara halayyar shan taba don su zama masu dacewa. Addua. 2009; 104: 1620 – 1622. [PMC free article] [PubMed]
  186. Peters J, Bromberg U, Schneider S, Brassen S, Menz M, Banaschewski T, Conrod PJ, Flor H, Gallinat J, Garavan H, et al. Activarancin tashin hankali na ventral na kunnawa yayin jiran sakamako a cikin masu shan sigari. American Journal of Psychiatry. 2011; 168: 540 – 549. [PubMed]
  187. Potenza MN, Hong KA, Lacadie CM, Fulbright KK, Tuit KL, Sinha R. Neural correlates of stress-induced and cue-induced craze: Tasirin yin jima'i da dokin. American Journal of Psychiatry. 2012; 169: 406 – 414. [PMC free article] [PubMed]
  188. Rao H, Mamikonyan E, Detre JA, Siderowf AD, Stern MB, Potenza MN, Weintraub D. Rage aikin ventral striatal tashin hankali tare da rikicewar rikicewar cuta a cikin cutar ta Parkinson. Rashin Harkokin motsi. 2010; 25: 1660 – 1669. [PMC free article] [PubMed]
  189. Reid MS, Casadonte P, Baker S, Sanfilipo M, Braunstein D, Hitzemann R, Montgomery R, ​​Majewska D, Robinson J, Rotrosen J. Gwajin binciken da ake sarrafa shi na olanzapine, valproate, da coenzyme Q10 / L-carnitine don lura da dogaro na koko. Addua. 2005; 100: 43 – 57. [PubMed]
  190. Reid MS, Ho LB, Berger SP. Sakamakon yanayin tsabtace muhalli kan haɓakar fahimtar abubuwan nicotine: Tsarin halaye da bincike na ƙwaƙwalwar ƙwaƙwalwa. Psychopharmacology. 1996; 126: 301 – 310. [PubMed]
  191. Reuter J, Raedler T, Rose M, Hannun I, Gläscher J, Büchel C. Gidan caca yana da alaƙa da rage kunnawa ladan tsarin sakamako na mesolimbic. Yanayin Neuroscience. 2005; 8: 147 – 148. [PubMed]
  192. Robinson MJ, Berridge KC. Sakamakon sakamako na yau da kullun, caca da jaraba: sake kunnawa don motsa sha'awa don lambobin yabo. Society for Neuroscience. 2012; 38: 605.3. Abubuwan kunya.
  193. Robinson TE, Becker JB. Dorewa canje-canje a cikin kwakwalwa da halayyar da aka samar ta hanyar maganin amphetamine na kullum: bita da kimantawa game da dabbobin dabbobi na psychology na amphetamine. Binciken Kwakwalwa. 1986; 396: 157 – 198. [PubMed]
  194. Robinson TE, Berridge KC. Tushen tushen maganin sha'awar miyagun ƙwayoyi: ka'idodi mai sa hankali-game da jaraba. Reviews Binciken Kwakwalwa. 1993; 18: 247 – 291. [PubMed]
  195. Robinson TE, Berridge KC. Addua. Nazarin Nazari na shekara-shekara na Ilimin halin .an Adam. 2003; 54: 25 – 53. [PubMed]
  196. Sato M. Dogara mai rauni zuwa ga psychosis a cikin marasa lafiya tare da methamphetamine psychosis na baya. Annals New York Cibiyar Kimiyya. 1992; 654: 160 – 170. [PubMed]
  197. Sato M, Numachi Y, Hamamura T. Sake dawo da yanayin tunanin psychotic a tsarin methamphetamine na schizophrenia. Bullarin Schizophrenia. 1992; 18: 115 – 122. [PubMed]
  198. Schacht JP, Anton RF, Randall PK, Li X, Henderson S, Myrick H. Stability na fMRI mawuyacin martani ga al'amuran barasa: tsarin ƙirar tsari. NeuroImage. 2011; 56: 61 – 68. [PMC free article] [PubMed]
  199. Schneider S, Peters J, Bromberg U, Brassen S, Medl SF, Banaschewski T, Barker GJ, Conrod PJ, et al. Samun haɗarin haɗari da tsarin sakamako na matasa: hanyar haɗi na gama gari don amfani da maye. American Journal of Psychiatry. 2012; 169: 39 – 46. [PubMed]
  200. Schoenmakers TM, de Bruin M, Lux IF, Goertz AG, Van Kerkhof DH, Wiers RW. Ingancin asibiti na atomatik gyaran tarbiyya a cikin marasa lafiyar giya. Magunguna da Shan Giya. 2010; 109: 30 – 36. [PubMed]
  201. Schott BH, Minuzzi L, Krebs RM, Elmenhorst D, Lang M, Winz OH, Seidenbecher CI, Coenen HH, Heinze HJ, Ziles K, Düzel E, Bauer A. Mesolimbic mai aiki da maganadisu game da tasirin tasirin tasirin a yayin da ake jiran lada da lada ventral striatal dopamine saki. Jaridar Neuroscience. 2008; 24: 14311 – 14319. [PubMed]
  202. Schuckit MA. Samun kansu game da maye giya da samari tare da kuma ba tare da tarihin iyali na giya ba. Jaridar Nazarin Alkahol. 1980; 41: 242 – 249. [PubMed]
  203. Schultz W, Dayan P, Montague PR. Matsayi mai mahimmanci na tsinkaya da lada. Kimiyya. 1997; 275: 1593-1599. [PubMed]
  204. Seo D, Jia Z, Lacadie CM, Tsou KA, Bergquist K, Sinha R. bambance-bambance na jima'i a cikin abubuwan da suka shafi yanayin damuwa da yanayin shaye-shaye. Tasirin Kwakwalwar Humanan Adam. 2011; 32: 1998 – 2013. [PMC free article] [PubMed]
  205. Setiawan E, Pihl RO, Casey KF, Dagher A, Benkelfat C, Leyton M. releaseara yawan sakin dopamine da ke cikin maye game da haɗarin dogaro da barasa: binciken PET [11C]. Taron Kwalejin Kanada na Neuropsychopharmacology; 2010. Matsalar.
  206. Siegel S. Matsayin sanya shara a cikin haƙuri da jaraba. A cikin: Keehn JD, editan. Psychopathology a cikin dabbobi: Bincike da Tasirin Jiyya. Press Press; New York: 1979. p. 143 – 168.
  207. Mawaƙa BF, Scott-Railton J, Vezina P. sacarfafa saccharin da ba a iya ambata ba tana haɓaka motsi ga amphetamine. Binciken Kwakwalwar Ihu. 2012; 226: 340 – 344. [PMC free article] [PubMed]
  208. Mawaƙa BF, Tanabe LM, Gorny G, Jake-Matthews C, Li Y, Kolb B, Vezina P. Amphetamine-ya haifar da canje-canje a cikin ƙwaƙwalwar dendritic a cikin ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwa ta dace da yanayin magani maimakon shawo kan miyagun ƙwayoyi. Ilimin halayyar dan adam. 2009; 65: 835 – 840. [PMC free article] [PubMed]
  209. Daramin DM, Jones-Gotman M, Dagher A. paddamar da dopamine ciyarwa cikin dorsal striatum yayi daidai da ƙimar abinci a cikin masu ba da agaji na ɗan adam. NeuroImage. 2003; 19: 1709 – 1715. [PubMed]
  210. Daramin DM, Zatorre RJ, Dagher A, Evans AC, Jones-Gotman M. Canje-canje a cikin aikin kwakwalwa wanda ke da alaƙa da cin cakulan: daga nishaɗi zuwa ƙi. Kwakwalwa 2001; 124: 1720 – 1733. [PubMed]
  211. Smelson DA, Williams J, Ziedonis D, Sussner BD, Losonczy MF, Engelhart C, Kaune M. Nazarin matattara mai sarrafa makaho mai hauka biyu game da risperidone don rage sha'awar cue-elicited a cikin marasa lafiya da aka kwantar da su a kwanan nan. Journal of Abuse magani Abun magani. 2004; 27: 45 – 49. [PubMed]
  212. Somerville LH, Jones RM, Casey BJ. Lokacin canji: halayya da dabi'un al'adu na jijiyoyin kai game da sha'awar abinci da kuma mahimmacin muhalli. Kwakwalwa da Girman kai. 2010; 72: 124 – 133. [PMC free article] [PubMed]
  213. Spear LP. Sakamakon sakamako, kyama da shafar balaga: abubuwan da ke haifar da fadada a tsakanin dabbobi da bayanan dabbobi. Ci gaban Kwarewar Nasihu. 2011; 1: 390 – 403. [PMC free article] [PubMed]
  214. Steeves TDL, Miyasaki J, Zurowski M, Lang AE, Pellecchia G, Van Eimeren T, Rusjan P, Houle S, Strafella AP. Asedarin mai kwance ɗarin kwayar cutar dopamine a cikin cututtukan ƙwayar cuta ta Parkinsonian: a [11C] nazarin PET na raclopride. Kwakwalwa 2009; 132: 1376 – 1385. [PMC free article] [PubMed]
  215. Stewart J. Rarraba hanyoyin amsawar janyewar opioid: sharhi kan McDonald da Siegel. Gwajin gwaji da na asibiti Psychopharmacology. 2004; 12: 20 – 22. [PubMed]
  216. Stewart J, de Wit H, Eikelboom R. Matsayin yanayin rashin daidaituwa da tasirin magunguna a cikin gudanarwar kai na abubuwan opiates da masu ƙarfafawa. Nazarin Ilimin Jima'i. 1984; 91: 251 – 268. [PubMed]
  217. Stewart J, Eikelboom R. Tasirin magunguna. A cikin: Iversen LL, Iversen SD, Snyder SH, masu gyara. Littafin Jagora na Psychopharmacology. Plenum Press; New York: 1987. p. 1 – 57.
  218. Stewart J, Vezina P. Yanayin zama da tsinkayen halaye. A: Kalivas PW, Barnes CD, masu gyara. Sirrin aiki a cikin Tsarin Tsarin ciki. Telford Press; Caldwell, New Jersey: 1988. p. 207 – 224.
  219. Stewart J, Vezina P. Tsarin haɓakawa yana hana sarrafa yanayin motsa jiki amma an kula da amsar da aka yiwa amphetamine. Dabarar Magunguna. 1991; 2: 65 – 71. [PubMed]
  220. Stoltenberg SF, Mudd SA, Blow FC, Hill EM. Kimanta matakan tarihin dangi game da barasa: yawanci da akasiyya. Addua. 1998; 93: 1511 – 1520. [PubMed]
  221. Strakowski SM, Sax KW. Amsar halayyar haɓaka halayyar d-amphetamine na maimaitawa: ƙarin tabbaci don fahimtar hankalin mutane. Ilimin halayyar dan adam. 1998; 44: 1171 – 1177. [PubMed]
  222. Strakowski SM, Sax KW, Rosenberg HL, DelBello MP, Adler CM. Amsar ɗan adam ga maimaita ƙarancin d-amphetamine: shaida don haɓaka halayyar da haƙuri. Neuropsychopharmacology. 2001; 25: 548 – 554. [PubMed]
  223. Strakowski SM, Sax KW, Setters MJ, Keck PE., Jr Ingantaccen martani ga kalubalantar d-amphetamine da aka maimaita: shaida don halayyar halayyar mutane. Ilimin halayyar dan adam. 1996; 40: 872 – 880. [PubMed]
  224. Suto N, Tanabe LM, Austin JD, Creekmore E, Pham CT, Vezina P. Fallasa abubuwan da suka gabata game da psychostimulants yana haɓaka sake dawo da maganin cocaine da ke buƙatar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwa ta AMP. Neuropsychopharmacology. 2004; 29: 2149 – 2159. [PubMed]
  225. Tang DW, ellowan Lan wasa LK, Dananan DM, Dagher A. Alamun abinci da magunguna suna kunna irin yankuna na kwakwalwa: ƙididdigar meta na nazarin MRI na aiki. Kimiyya da Halaye. 2012; 106: 317 – 324. [PubMed]
  226. Tarter RF, Kirisci L, Mezzich A, Cornelius JR, Pajer K, Vanyukov M, Gardner W, Blackson T, Clark D. Neurobiological dishibition a cikin yara yana annabta farkon tsufa a farkon amfani da matsala. American Journal of Psychiatry. 2003; 160: 1078 – 1085. [PubMed]
  227. Thompson JL, Urban N, Slifstein M, Xu X, Kegels LS, Girgis RR, Beckeman Y, Harkavy-Friedman JM, Gil R, Abi-Dargham A. Striatal dopamine saki a cikin schizophrenia comorbid tare da dogara da abu. Kwayar Halittar Jiki. a latsa. [PMC free article] [PubMed]
  228. Tiffany ST. Kyakkyawar samfurin maganin miyagun ƙwayoyi da kuma amfani da miyagun ƙwayoyi: rawar da ƙirar atomatik da ƙa'idodin. Nazarin Psychological. 1990; 97: 147-168. [PubMed]
  229. Toates F. Tsarin Motsawa. Jami'ar Cambridge Press; Cambridge, Ingila: 1986.
  230. Tolivar BK, McRae-Clark AL, Saladin M, Farashin KL, Simpson AN, DeSantis SM, Baker NL, Brady KT. Tabbatattun abubuwan buƙata na cue-elicited buƙatu da kuma farfadowa na jiki a cikin batutuwa masu dogara da methamphetamine a cikin dakin gwaje-gwaje. Jaridar nan ta Amurka ta Ruwa da Almubazzaranci. 2010; 36: 106 – 113. [PubMed]
  231. Tran-Nguyen LTL, Fuchs RA, Coffey GP, Baker DA, O'Dell LE, Neisewander JL. Canje-canje na lokaci-lokaci a cikin yanayin halayen hodar Iblis da matakan dopamine na extracellular a cikin amygdala yayin janyewar hodar. Neuropsychopharmacology. 1998; 19: 48 – 59. [PubMed]
  232. Treadway MT, Buckholtz JW, Cowan RL, Woodward ND, Li R, Ansari MS, Baldwin RM, Schwartzman AN, Kessler RM, Zald DH. Hanyoyin Dopaminergic na bambance-bambance na mutum a cikin shawarar yanke shawarar mutum. Jaridar Neuroscience. 2012; 32: 6170 – 6176. [PMC free article] [PubMed]
  233. Tsuang MT, Lyons MJ, Meyer JM, Doyle T, Éisen SA, Goldberg J, Gaskiya W, Lin N, Toomey R, Eaves L. Co -ukuwa na cin zarafin kwayoyi daban-daban a cikin maza. Sanarwa na Janar Psychiatry. 1998; 55: 967 – 972. [PubMed]
  234. Urban NBL, Slifstein M, Thompson JL, Xu X, Girgis RR, Raheja S, Haney M, Abi-Dargham A. sakewa a Dopamine a cikin masu amfani da cannabis na kullum: Nazarin [11C] raclopride positron emmo tomography tomography. Ilimin halayyar dan adam. 2012; 71: 677 – 683. [PMC free article] [PubMed]
  235. van Holst RJ, Veltman DJ, Büchel C, van den Brink W, Goudriaan AE. Rubutun da ake tsammani na gurguzu cikin matsalar caca: Shin mai jaraba ne cikin jira? Ilimin halayyar dan adam. 2012; 71: 741 – 748. [PubMed]
  236. Vanderschuren LJ, Kalivas PW. Canje-canje a cikin dopaminergic da watsawar glu-tamatergic a cikin shigowa da bayyanar hankalin halayen. Nazari mai mahimmanci na karatun da ya dace. Psychopharmacology. 2000; 51: 99 – 120. [PubMed]
  237. Venugopalan VV, Casey KF, O'Hara C, O'Loughlin J, Benkelfat C, Fellows LK, Leyton M. Matsanancin phenylalanine / tyrosine depletion yana rage rage motsa sigari a cikin matakan shaye-shaye. Neuropsychopharmacology. 2011; 36: 2469 – 2476. [PMC free article] [PubMed]
  238. Vezina P. Sensitization of midbrain dopamine neuron amsawa da kuma kai shugabancin psychomotor stimulant kwayoyi. Neuroscience da Biobehavioral Reviews. 2004; 27: 827-839. [PubMed]
  239. Vezina P. Sensitization, jaraba na miyagun ƙwayoyi da psychopathology a cikin dabbobi da mutane. Ci gaba a cikin Neuro-Psychopharmacology da ilimin halayyar halittu. 2007; 31: 1553 – 1555. [PMC free article] [PubMed]
  240. Vezina P, Leyton M. Bayyanannun yanayi da kuma nuna yanayin motsawar sha'awa a cikin dabbobi da mutane. Neuropharmacology. 2009; 56: 160 – 168. [PMC free article] [PubMed]
  241. Vezina P, Lorrain DS, Arnold GM, Austin JD, Suto N. Sensitization midbrain dopamine neuron reactivity yana haɓaka bin amphetamine. Jaridar Neuroscience. 2002; 22: 4654 – 4662. [PubMed]
  242. Vezina P, McGehee DS, Green WN. Bayyanar yanayin nicotine da tsinkayen halayen da ke haifar da nicotine. Ci gaba a cikin Neuro-Psychopharmacology da ilimin halayyar halittu. 2007; 31: 1625 – 1638. [PMC free article] [PubMed]
  243. Vezina P, Stewart J. Amphetamine ana gudanar da su a yankin ventral tegmental amma ban da nucleus accumbens yana ba da hankalin mutum ga beraye ga tsarin morphine: rashin tasirin sakamako. Binciken Kwakwalwa. 1990; 516: 99 – 106. [PubMed]
  244. Vogel VH, Isbell H, Chapman KW. Matsayi na halin jaraba. Jaridar Medicalungiyar Likitocin Amurka. 1948; 138: 1019 – 1026. [PubMed]
  245. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Hitzemann R, et al. Rage rage jin daɗin maganin maganin maganin maganin cocaine. Yanayi. 1997; 386: 830-833. [PubMed]
  246. Volkow ND, Wang GJ, Fowler JS, Logan J, Jayne M, Franceschi D, Wong C, Gatley SJ, Gifford AN, Ding YS, Pappas N. Rashin himma na abinci a cikin mutane ya shafi dopamine a cikin maganin tashin hankali da methylphenidate yana haɓaka wannan sakamako. Synapse. 2002; 44: 175 – 180. [PubMed]
  247. Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Yarinyar AR, et al. Cocaine cues da dopamine a cikin maganin ƙaddara: hanyar sha'awar jaraba ta cocaine. Jaridar Neuroscience. 2006; 26: 6583 – 6588. [PubMed]
  248. Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Childress AR, Jayne M, Ma Y, Wong C. Dopamine ya karu a cikin tashin hankali ba su ba da izinin cin zarafin barayin har sai an haɗu da sunayen cakulan. NeuroImage. 2008; 39: 1266 – 1273. [PMC free article] [PubMed]
  249. Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Jayne M, Ma Y, Pradhan K, Wong C. Babban raguwa a cikin sakin dopamine a cikin shaye-shaye a cikin masu maye giya: yiwuwar shiga orbitofrontal shiga. Jaridar Neuroscience. 2007; 27: 12700 – 12706. [PubMed]
  250. Volkow ND, Wang GJ, Fowler JS, Telang F, Maynard L, Logan J, Gatley SJ, Pappas N, Wong C, Vaska P, Zhu W, Swanson JM. Shaida cewa methylphenidate yana haɓaka ƙoshin aiki na lissafi ta hanyar ƙara dopamine a cikin kwakwalwar mutum. American Journal of Psychiatry. 2004; 161: 1173 – 1180. [PubMed]
  251. Vollstädt-Klein S, Loeber S, Richter A, Kirsch M, Bach P, von der Goltz C, Hermann D, Mann K, Kiefer F. Ingantaccen zartar da siginar hoto tare da aikin tasirin magnetic resonance hoto: haɗin tsakanin mesolimbic cue reactivity da kuma nuna fifiko a cikin giya -tasasshen marasa lafiya. Labarin Batsa. 2011; 17: 807 – 816. [PubMed]
  252. Vollstädt-Klein S, Wichert S, Rabinstein J, Bühler M, Klein O, Ende G, Hermann D, Mann K. Abubuwan farko, al'ada da tilasta amfani da giya ana bayyana su ta hanyar juye juye na sarrafawa daga iska zuwa layin dorsal. Addua. 2010; 105: 1741 – 1749. [PubMed]
  253. Volpp KG, Troxel AB, Pauly MV, Glick HA, Puig A, Asch DA, Galvin R, Zhu J, Wan F, DeGuzman J, Corbett E, Weiner J, Audrain-McGovern J. Jarrabawar sarrafa kudi ta hanyar rashin kudi dainawa. Jaridar New England Journal of Medicine. 2009; 360: 699 – 709. [PubMed]
  254. Wachtel SR, de Wit H. jectarfin magana da sakamakon halayyar d-amphetamine mai maimaitawa a cikin mutane. Dabarar Magunguna. 1999; 10: 271 – 281. [PubMed]
  255. Wan X, Nakatani H, Ueno K, Asamizuya T, Cheng K, Tanaka K. Tsarin halitta na mafi kyau wanda yafi dacewa a gaba wajen tsara masana. Kimiyya. 2011; 21: 341-346. [PubMed]
  256. Wang GJ, Geliebter A, Volkow ND, Telang FW, Logan J, Jayne MC, Galanti K, Selig PA, Han H, Zhu W, Wong CT, Fowler JS. Ingantaccen damuwar dopamine mai fitarwa yayin motsa abinci yayin tashin hankali na rashin abinci. Kiba. 2011; 19: 1601 – 1608. [PMC free article] [PubMed]
  257. Wang GJ, Smith L, Volkow ND, Telang F, Logan F, Tomasi D, Wong CT, Hoffman W, Jayne M, Alia-Klein N, Thanos P, Fowler JS. Rage aikin dopamine ya ƙaddara komacewa cikin masu lalata methamphetamine. Kwayar Halittar Jiki. 2012; 17: 918 – 925. [PMC free article] [PubMed]
  258. Ruwa AJ, Marhe R, Franken IH. Rashin hankali ga al'amuran miyagun ƙwayoyi yana daɗaɗawa kafin da lokacin gwaji don amfani da tabar heroin da hodar Iblis. Psychopharmacology. 2012; 219: 909 – 921. [PubMed]
  259. Weiss F, Maldonado-Vlaar CS, Parsons LH, Kerr TM, Smith DL, Ben-Shahar O. Gudanar da halayyar hodar iblis ta hanyar ƙwayoyi masu haɗari a cikin beraye: tasirin akan dawo da aikin mai kashewa da amsawa da kuma ƙara yawan ƙwayoyin dopamine a cikin amygdala da kwayoyin nucleus. Ayyukan Kwalejin Kimiyya ta Kasa. 2000; 97: 4321 – 4326. [PMC free article] [PubMed]
  260. Wikler A. Ci gaban kwanannan a cikin bincike game da tushen ƙwaƙwalwar ƙwaƙwalwar ƙwayar ƙwaƙwalwa. American Journal of Psychiatry. 1948; 105: 329 – 338. [PubMed]
  261. Wikler A. Tasirin magunguna. Tasirin ka'idar yanayin motsa jiki don bincike da magani. Sanarwa na Janar Psychiatry. 1973; 28: 611 – 616. [PubMed]
  262. Winkielman P, Berridge KC, Wilbarger JL. Sakamakon abin da ya shafi yanayin farin ciki a fuskokin farin ciki da fushin fuskoki suna tasiri halayen ci da hukunci na darajar. Labarin mutum da Bullar ilimin halin dan adam. 2005; 31: 121 – 135. [PubMed]
  263. Wong DF, Kuwabara H, Schretlen DJ, Bonson KR, Zhou Y, Nandi A, et al. Ara yawan masu karɓa na dopamine a cikin tasirin ɗan adam yayin sha'awar hodar Iblis. Neuropsychopharmacology. 2006; 31: 2716 – 2727. [PubMed]
  264. Goge J, Schlagenhauf F, Kienast T, Wüstenberg T, Bermpohl F, Kahnt T, Beck A, Ströhle A, Juckel G, Knutson B, Heinz A. Rage aikin lada yana daidaitawa da sha'awar giya a cikin maye. NeuroImage. 2007; 35: 787 – 794. [PubMed]
  265. Wray JM, Godleski SA, Tiffany ST. Cake-reactivity a yanayin dabi'ar masu shan sigari: tasirin daukar hoto da kuma a cikin motsawar sigari a cikin vivo. Ilimin halin dan Adam na Addictive Behaviors. 2011; 4: 733 – 737. [PMC free article] [PubMed]
  266. Yang Z, Xie J, Shao YC, Xie CM, Fu LP, Li DJ, Fan M, Ma L, Li SJ. Responarfafa ƙwayar jijiya na kwatancen kwalliya don nuna alama a cikin masu amfani da tabar heroin: nazarin fMRI. Tasirin Kwakwalwar Humanan Adam. 2009; 30: 766 – 775. [PubMed]
  267. Yau WYW, Zubieta JK, Weiland BJ, Samudra PG, Zucker RA, Heitzeg MH. Tasirin nukiliya ya ba da amsa ga sha'awar motsa jiki a cikin yara masu shan giya: alaƙa tare da haɗarin halayyar halayyar halayyar barasa da rayuwa. Jaridar Neuroscience. 2012; 32: 2544 – 2551. [PMC free article] [PubMed]
  268. Yoder KK, Morris ED, Constantinescu CC, Cheng TE, Normandin MD, O'Connor SJ, Kareken DA. Lokacin da abin da kake gani ba shine abin da kake samu ba: ƙididdigar bugun giya, gudanarwar giya, kuskuren tsinkaya, da kuma maganin ɗan adam. Alcoholism: Clinical da Gwajin Nazari. 2009; 33: 139 – 149. [PMC free article] [PubMed]
  269. Zald DH, Boileau I, El-Dearedy W, Gunn R, McGlone F, Ditcher GS, watsawar Dagher A. Dopamine a cikin aikin mutum yayin ayyukan lada. Jaridar Neuroscience. 2004; 28: 4104 – 4112. [PubMed]
  270. Zhao LY, Tian J, Wang W, Qin W, Shi J, Li Q, Yuan K, Dong MH, Yang WC, Wang YR, Sun LL, Lu L. Matsin dorsal na baya na cingulate cortex a cikin ka'idar sha'awar ta sake karantawa a cikin masu shan sigari. PLoS Daya. 2012a; 7: e43598. [PMC free article] [PubMed]
  271. Zhao M, Fan C, Du J, Jiang H, Chen H, Sun H. Cue-induced nema da kuma martani a fagen ilimin likitanci a kwanannan da marasa lafiya masu dogaro da jinsi. Beabi'a masu jaraba. 2012b; 37: 393 – 398. [PMC free article] [PubMed]
  272. Ziauddeen H, Farooqi NE, Fletcher PC. Kiba da kwakwalwa: yaya tabbatuwa ce tsarin jaraba? Yanayin Nazarin Yanayi. 2012; 13: 279 – 286. [PubMed]
  273. Zijlstra F, Booij J, van den Brink W, Franken IHA. D2 mai ɗaukar Dopamine mai ɗaukar nauyi da sakin dopamine yayin ƙwararrun abubuwan da aka samu na kwatankwacin maza na dogaro mai dorewa. Turai Neuropsychopharmacology. 2008; 18: 262 – 270. [PubMed]
  274. Zijlstra F, Veltman DJ, Booij J, van den Brink W, Franken IHA. Neurobiological abubuwa na cue-elicited marmarin da anhedonia a kwanan nan m maza opioid-dogara maza. Magunguna da Shan Giya. 2009; 99: 183 – 192. [PubMed]
  275. Zimmer BA, Oleson EB, Roberts DCS. Increasedarfafa don gudanar da aikin kai yana ƙaruwa ne bayan da tarihin yaduwar matakan ƙwaƙwalwar cocaine. Neuropsychopharmacology. 2012; 37: 1901 – 1910. [PMC free article] [PubMed]
  276. Zinkernagel C, Naef MR, Bucher HC, Ladewig D, Gyr N, Battegay M. Onset da kuma yadda ake amfani da sinadarai cikin masu amfani da magunguna masu guba na shirin tallafi na opiate. Magunguna da Shan Giya. 2001; 64: 105 – 109. [PubMed]